var title_f19_14_19680="Cherry red spot";
var content_f19_14_19680=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65650&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65650&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Macular cherry red spot",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 309px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sphingolipids accumulate in the retinal ganglion cells in the perifoveal area of patients with sphingolipidoses causing the perifoveal area to appear pale. The fovea, which has no ganglion cells, retains its \"cherry red\" color.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert P Cruse, DO.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19680=[""].join("\n");
var outline_f19_14_19680=null;
var title_f19_14_19681="RTT pseudostationary b";
var content_f19_14_19681=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rett syndrome, pseudostationary",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This girl with RTT demonstrated prominent motor dysfunction but experienced no further cognitive decline.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Glaze DG, Schultz RJ. Rett syndrome: Meeting the challenge of this gender-specific neurodevelopmental disorder. Medscape Women's Health 1997; 2. Copyright &copy; 1997 Medscape.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19681=[""].join("\n");
var outline_f19_14_19681=null;
var title_f19_14_19682="Halo nevus";
var content_f19_14_19682=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65988&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65988&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Halo nevus (Sutton's nevus)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Stage I halo nevus with a characteristic depigmented rim.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jean L Bolognia, MD, and Julie V Schaffer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19682=[""].join("\n");
var outline_f19_14_19682=null;
var title_f19_14_19683="Rectovaginal exam during laparoscopy";
var content_f19_14_19683=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F50155&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F50155&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rectovaginal examination during laparoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 346px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: LifeART. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19683=[""].join("\n");
var outline_f19_14_19683=null;
var title_f19_14_19684="Autonomic dysfunction in dialysis patients";
var content_f19_14_19684=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Autonomic dysfunction in dialysis patients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/14/19684/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19684/contributors\">",
"     William L Henrich, MD, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/14/19684/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19684/contributors\">",
"     Steve J Schwab, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/14/19684/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19684/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/14/19684/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autonomic dysfunction (dysautonomia) occurs in over 50 percent of patients on maintenance dialysis, and may be most important clinically by contributing to hypotension during dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/1\">",
"     1",
"    </a>",
"    ]. The presence of a defect in the autonomic nervous system has been confirmed by performing a series of tests that evaluate the different aspects of this system.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Valsalva test probes the integrity of the entire autonomic nervous system: low and high pressure baroreceptors in the cardiopulmonary circulation, the afferent and efferent limbs of these pathways, and both sympathetic and parasympathetic function [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/2\">",
"       2",
"      </a>",
"      ]. This test is therefore useful in detecting a defect, but not in identifying the site of the abnormality.",
"     </li>",
"     <li>",
"      An amyl nitrate inhalation test may be used to test low pressure baroreceptors and the resultant efferent sympathetic outflow expected when blood pressure declines [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The cold pressor test (performed by placing a cold cloth on the patient's forehead or by submerging a hand in ice slush) predominantly reflects efferent sympathetic function activated by cold-induced peripheral vasoconstriction [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most consistently described autonomic defect in dialysis patients resides in the",
"    <span class=\"nowrap\">",
"     baroreceptor/afferent",
"    </span>",
"    side of the autonomic loop (ie, abnormal amyl nitrate but normal cold pressor response) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. The impairment in baroreceptor function minimizes the reflex increase in circulating catecholamines (and antidiuretic hormone) that should be induced when hypotension occurs in a patient on hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/2,7,8\">",
"     2,7,8",
"    </a>",
"    ]. This defect may be most prominent in patients with severe recurrent hypotension [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ROLE IN DIALYSIS-INDUCED HYPOTENSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of autonomic dysfunction can also impair the patient's ability to maintain the systemic blood pressure following a large degree of fluid removal by ultrafiltration. A decline in volume in normal subjects leads to activation of the low pressure baroreceptors and a subsequent increase in efferent sympathetic activity [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/9\">",
"     9",
"    </a>",
"    ]. The ensuing rise in systemic vascular resistance minimizes the reduction in blood pressure.",
"   </p>",
"   <p>",
"    By comparison, a disproportionate number of patients with frequent hypotensive episodes during dialysis have autonomic dysfunction that impairs this homeostatic response [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/5,7,8,10,11\">",
"     5,7,8,10,11",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Downregulation of alpha-adrenergic receptors has been noted, an abnormality that will diminish the hemodynamic response to endogenous catecholamines [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Activation of the Bezold-Jarisch reflex, which involves decreased sympathetic and increased parasympathetic nervous system activity, may also occur with ultrafiltration, causing sudden intradialytic hypotension [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/10,11\">",
"       10,11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The likelihood of these patients developing symptoms is increased when other protective maneuvers (such as a higher dialysate sodium concentration or the use of bicarbonate as a dialysate buffer) are not utilized [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31240?source=see_link\">",
"     \"Hemodynamic instability during hemodialysis: Overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite the frequent presence of autonomic dysfunction, baseline plasma catecholamine levels are often elevated in chronic renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/8\">",
"     8",
"    </a>",
"    ]. Increased sympathetic tone (perhaps mediated by renal afferents), decreased degradation, and diminished neuronal reuptake all may contribute to this finding. The physiologic significance of this finding is uncertain but sympathetic overactivity could contribute to the common development of hypertension in end-stage renal disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ROLE IN CHRONIC HYPOTENSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small fraction of hemodialysis patients have difficulty maintaining a normal blood pressure and are chronically hypotensive",
"    <strong>",
"     between",
"    </strong>",
"    dialysis treatments. In a national sample of nearly 4500 dialysis patients, the presence of a low predialysis systolic blood pressure (less than 110 mmHg) was significantly associated with an elevated mortality rate (relative risk of 1.86, P&lt;0.0001) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of autonomic dysfunction in this condition was examined in one study which compared numerous measures of autonomic function among hypotensive hemodialysis (HD) patients, normotensive HD patients, and control patients (all groups consisted of 17 individuals) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/14\">",
"     14",
"    </a>",
"    ]. As observed with patients prone to low blood pressure during dialysis (see above), chronically hypotensive individuals exhibited a significant downregulation of alpha and beta adrenergic receptors, suggesting an inability to produce an adequate sympathetic response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ROLE IN ARRHYTHMIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of myocardial dysfunction, fluid and electrolyte shifts, poor oxygen saturation, and other factors, either alone or in combination, favor the development of cardiac arrhythmias in end-stage renal disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26584?source=see_link\">",
"     \"Myocardial dysfunction in end-stage renal disease\"",
"    </a>",
"    .) A previously unrecognized predisposing factor may be autonomic dysfunction. One study of 41 dialysis patients evaluated the correlation between arrhythmia (as determined by 24 hour Holter examination) and autonomic dysfunction (as determined by blood pressure and heart rate responses) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/15\">",
"     15",
"    </a>",
"    ]. Compared to patients with normal autonomic function, a significantly increased incidence of atrial",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ventricular arrhythmia was found among those with one or more autonomic abnormalities (41 abnormal rhythms in 26 patients with autonomic dysfunction versus 1 in 15 with normal autonomic responses)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unfortunately, there has been no specific or effective therapy for autonomic dysfunction in dialysis patients. The administration of agents such as ephedrine (a nonselective alpha and beta adrenergic agonist) or a nonsteroidal antiinflammatory drug (to reduce the production of vasodilator prostaglandins) has been generally unrewarding. It is possible, however, that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/35/2613?source=see_link\">",
"     midodrine",
"    </a>",
"    , a selective alpha-1 adrenergic agonist, might provide benefit in these patients. Its efficacy in patients with a variety of neurogenic causes of orthostatic hypotension was demonstrated in a double-blind trial in which 162 patients were randomized to midodrine (10 mg TID) or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/16\">",
"     16",
"    </a>",
"    ]. Midodrine produced greater improvement in lightheadedness and in standing systolic blood pressure (20 versus 5 mmHg) than placebo. The major side effects of midodrine include piloerection, urinary retention, supine hypertension (which can be relieved by elevating the head of the bed), paresthesias, and pruritus.",
"   </p>",
"   <p>",
"    Similar benefits were noted in a smaller study of 21 patients with severe hypotension (&ge;30 mmHg fall in systolic pressure with associated symptoms) occurring during dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/17\">",
"     17",
"    </a>",
"    ]. At a mean dose of 8 mg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/35/2613?source=see_link\">",
"     midodrine",
"    </a>",
"    increased both the mean minimum systolic pressure during dialysis (93 to 107 mmHg) and the postdialysis systolic pressure (116 to 130 mmHg); each value represented the mean of five dialysis treatments. The drug was well tolerated.",
"   </p>",
"   <p>",
"    Preliminary evidence suggests that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    , a central nervous system serotonin reuptake inhibitor, may also be beneficial in dialysis-induced hypotension [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19684/abstract/18\">",
"     18",
"    </a>",
"    ]. A retrospective study of nine patients placed on sertraline (50 to 100",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    for depression compared the blood pressure response during dialysis for the six week period prior to drug initiation to the response during an equivalent period immediately after the drug was begun. Sertraline was associated with an increase in the lowest mean blood pressure measured during dialysis (68 versus 55 mmHg, p&lt;0.05), a lower frequency of hypotensive episodes (0.6 versus 1.4 episodes per session, p&lt;0.005), and fewer required therapeutic interventions for hypotension during the study period (1.7 versus 11.0, p&lt;0.005). This benefit may be due to an attenuation of sympathic withdrawal. While more experience is needed with this drug, we have instituted therapy in several problem hypotensive patients to treat hypotension.",
"   </p>",
"   <p>",
"    Treatment should also be directed at other maneuvers designed to improve the tolerance to ultrafiltration including alterations in the dialysate composition and temperature. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31240?source=see_link\">",
"     \"Hemodynamic instability during hemodialysis: Overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H373488081\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Autonomic dysfunction (dysautonomia) occurs in over 50 percent of patients on maintenance dialysis and contributes to hypotension during, and occasionally in between dialysis. The most consistently described autonomic defect in dialysis patients resides in the",
"      <span class=\"nowrap\">",
"       baroreceptor/afferent",
"      </span>",
"      side of the autonomic loop which minimizes the reflex increase in circulating catecholamines (and antidiuretic hormone) that should be induced when hypotension occurs in a patient on hemodialysis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Role in dialysis-induced hypotension'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Role in chronic hypotension'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of autonomic dysfunction can impair the patient's ability to maintain the systemic blood pressure following a large degree of fluid removal by ultrafiltration. The likelihood of patients developing hypotension is increased when other protective maneuvers (such as a higher dialysate sodium concentration or the use of bicarbonate as a dialysate buffer) are not utilized. &nbsp; (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Role in dialysis-induced hypotension'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31240?source=see_link\">",
"       \"Hemodynamic instability during hemodialysis: Overview\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In addition to other factors such as myocardial dysfunction, fluid and electrolyte shifts, poor oxygen saturation, autonomic dysfunction may favor the development of cardiac arrhythmias in end-stage renal disease. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Role in arrhythmias'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is no specific or effective therapy for autonomic dysfunction in dialysis patients.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/35/2613?source=see_link\">",
"       Midodrine",
"      </a>",
"      , a selective alpha-1 adrenergic agonist, or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"       sertraline",
"      </a>",
"      , a central nervous system serotonin reuptake inhibitor may provide benefit in such patients. Treatment should also be directed at other maneuvers designed to improve the tolerance to ultrafiltration including alterations in the dialysate composition and temperature. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31240?source=see_link\">",
"       \"Hemodynamic instability during hemodialysis: Overview\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/1\">",
"      Ewing DJ, Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron 1975; 15:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/2\">",
"      SHARPEY-SCHAFER EP. Effects of Valsalva's manoeuvre on the normal and failing circulation. Br Med J 1955; 1:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/3\">",
"      Lazarus JM, Hampers CL, Lowrie EG, Merrill JP. Baroreceptor activity in normotensive and hypertensive uremic patients. Circulation 1973; 47:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/4\">",
"      Henrich WL. Autonomic insufficiency. Arch Intern Med 1982; 142:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/5\">",
"      Lilley JJ, Golden J, Stone RA. Adrenergic regulation of blood pressure in chronic renal failure. J Clin Invest 1976; 57:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/6\">",
"      Nies AS, Robertson D, Stone WJ. Hemodialysis hypotension is not the result of uremic peripheral autonomic neuropathy. J Lab Clin Med 1979; 94:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/7\">",
"      Friess U, Rascher W, Ritz E, Gross P. Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant 1995; 10:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/8\">",
"      Daul AE, Wang XL, Michel MC, Brodde OE. Arterial hypotension in chronic hemodialyzed patients. Kidney Int 1987; 32:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/9\">",
"      Kong CH, Thompson FD. Hemodynamic responses to head-up tilt in uremic patients. Clin Nephrol 1990; 33:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/10\">",
"      Converse RL Jr, Jacobsen TN, Jost CM, et al. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest 1992; 90:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/11\">",
"      Barnas MG, Boer WH, Koomans HA. Hemodynamic patterns and spectral analysis of heart rate variability during dialysis hypotension. J Am Soc Nephrol 1999; 10:2577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/12\">",
"      Velez RL, Woodard TD, Henrich WL. Acetate and bicarbonate hemodialysis in patients with and without autonomic dysfunction. Kidney Int 1984; 26:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/13\">",
"      Port FK, Hulbert-Shearon TE, Wolfe RA, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999; 33:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/14\">",
"      Esforzado Armengol N, Cases Amen&oacute;s A, Bono Illa M, et al. Autonomic nervous system and adrenergic receptors in chronic hypotensive haemodialysis patients. Nephrol Dial Transplant 1997; 12:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/15\">",
"      Jassal SV, Coulshed SJ, Douglas JF, Stout RW. Autonomic neuropathy predisposing to arrhythmias in hemodialysis patients. Am J Kidney Dis 1997; 30:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/16\">",
"      Low PA, Gilden JL, Freeman R, et al. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 1997; 277:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/17\">",
"      Flynn JJ 3rd, Mitchell MC, Caruso FS, McElligott MA. Midodrine treatment for patients with hemodialysis hypotension. Clin Nephrol 1996; 45:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19684/abstract/18\">",
"      Dheenan S, Venkatesan J, Grubb BP, Henrich WL. Effect of sertraline hydrochloride on dialysis hypotension. Am J Kidney Dis 1998; 31:624.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1956 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.25.216.6-E8883028DF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19684=[""].join("\n");
var outline_f19_14_19684=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H373488081\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ROLE IN DIALYSIS-INDUCED HYPOTENSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ROLE IN CHRONIC HYPOTENSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ROLE IN ARRHYTHMIAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H373488081\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31240?source=related_link\">",
"      Hemodynamic instability during hemodialysis: Overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26584?source=related_link\">",
"      Myocardial dysfunction in end-stage renal disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_14_19685="Differences between angiotensin converting enzyme inhibitors and receptor blockers";
var content_f19_14_19685=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Differences between angiotensin converting enzyme inhibitors and receptor blockers",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/14/19685/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19685/contributors\">",
"     Timothy W Smith, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19685/contributors\">",
"     James P Morgan, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/14/19685/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19685/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/14/19685/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19685/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/14/19685/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiotensin converting enzyme (ACE) inhibitors are widely used in the treatment of hypertension. They have also been effective in a number of other disorders, prolonging survival in patients with heart failure, coronary heart disease, and acute myocardial infarction, and slowing the rate of progression in chronic renal failure, particularly diabetic nephropathy. One limiting side effect in a minority of patients is cough, a side effect that does not appear to occur with increased frequency with the angiotensin receptor blockers (ARBs), which are as effective as the ACE inhibitors in the treatment of hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19685/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/40/25224?source=see_link\">",
"     \"Renin-angiotensin system inhibition in the treatment of hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evidence that there are clinically important differences between these two classes of drugs will be reviewed here. The major side effects of these drugs are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/2/18473?source=see_link\">",
"     \"Major side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MECHANISMS OF ACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiotensin II is an oligopeptide of eight amino acids, formed from its precursor, angiotensinogen by a series of two enzymatic cleavages. Angiotensinogen is released into the circulation by the liver. Renin, produced by the kidney, in response to glomerular hypoperfusion, catalyzes cleavage of angiotensinogen to angiotensin I, an inactive decapeptide. Angiotensin I is in turn cleaved by angiotensin converting enzyme to produce angiotensin II. Angiotensin II binds to its specific receptors and exert its effects in the brain, kidney, adrenal, vascular wall, and the heart. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/25/13720?source=see_link\">",
"     \"Chapter 2B: Renin-angiotensin system\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are two well-described subtypes of angiotensin II receptors, designated AT1 and AT2, both of which have a high affinity for angiotensin II [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19685/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The AT1 subtype mediates the vasoconstrictor effect of angiotensin II and is generally thought to mediate angiotensin II-induced growth in the left ventricle and the arterial wall [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19685/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The actions of the AT2 receptor are less well understood. AT2 receptors are expressed in greater abundance in fetal tissues, followed by a decline in expression after birth [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19685/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]. Their role in development has not been elucidated [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19685/abstract/3,4\">",
"       3,4",
"      </a>",
"      ]. In vivo data in a model of angiotensin II-induced hypertension showed that exposure of a specific inhibitor of the AT2 receptor (PD123319) prevented angiotensin II-induced arterial hypertrophy [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19685/abstract/7\">",
"       7",
"      </a>",
"      ]. This and other observations suggest that the AT2 receptor plays a greater role in stimulating growth in the arterial wall.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Receptor activation",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two major differences between the ACE inhibitors and angiotensin II receptor antagonists: the receptors that are affected; and the effect on kinins (",
"    <a class=\"graphic graphic_figure graphicRef55726 \" href=\"UTD.htm?9/23/9597\">",
"     figure 1",
"    </a>",
"    ). Angiotensin II can activate both AT1 and AT2 receptors. As a result, inhibition of angiotensin II formation with an ACE inhibitor will diminish the activity of both receptor subtypes. The inhibition of angiotensin II production occurs both systemically and at tissue sites of local renin-angiotensin systems. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/61/36825?source=see_link\">",
"     \"Actions of angiotensin II on the heart\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, the angiotensin II receptor antagonists only diminish AT1 activity. Thus, there is no change in AT2 receptor-mediated effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Effect on kinins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Converting enzyme is also a",
"    <strong>",
"     kininase",
"    </strong>",
"    . As a result, inhibiting this enzyme with an ACE inhibitor may lead to increased kinin levels, an effect not seen with the angiotensin II receptor antagonists. It is presumed that the absence of kinin accumulation accounts for the lack of cough with the angiotensin II receptor antagonists. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/2/18473?source=see_link\">",
"     \"Major side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers\"",
"    </a>",
"    .) However, kinin accumulation may also mediate some of the beneficial effects of ACE inhibition.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased kinins may contribute to the hypotensive action of ACE inhibitors by releasing nitric oxide from vascular endothelial cells. The potential importance of kinins in this response was illustrated in a study in humans who were treated with an ACE inhibitor (quinaprilat), or a bradykinin B2-receptor antagonist (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/36/4675?source=see_link\">",
"       icatibant",
"      </a>",
"      ), or both [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19685/abstract/8\">",
"       8",
"      </a>",
"      ]. ACE inhibition increased flow-dependent vasodilation (as determined by ultrasound and Doppler of the radial artery); this effect was abolished, and flow-dependent vasodilation was actually reversed by the addition of the bradykinin B2 receptor antagonist. The effect of the combination was similar to that seen with icatibant alone.",
"     </li>",
"     <li>",
"      A significant role for bradykinin in the induction of hypotension with ACE inhibitors was also found in a single-blinded, randomized study of 20 normotensive and 7 hypertensive individuals [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19685/abstract/9\">",
"       9",
"      </a>",
"      ]. An ACE inhibitor alone (25 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/59/9145?source=see_link\">",
"       captopril",
"      </a>",
"      ), captopril plus a bradykinin B2-receptor antagonist (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/36/4675?source=see_link\">",
"       icatibant",
"      </a>",
"      ), an angiotensin II subtype 1-receptor antagonist alone (75 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"       losartan",
"      </a>",
"      ) and placebo were randomly administered on four separate study days. Icatibant significantly ameliorated the hypotensive response to captopril (10.5 versus 15.0 mmHg for combination therapy and captopril alone, respectively, p = 0.001); in addition, combination therapy resulted in the same degree of blood pressure lowering as that observed with losartan alone (10.5 versus 11.0 mmHg). The elevation in plasma renin activity associated with ACE inhibition was reversed with icatibant, suggesting that bradykinin was responsible for this effect.",
"     </li>",
"     <li>",
"      Increased kinins may contribute to another effect of ACE inhibitors, the ability to improve insulin sensitivity which can lower the blood glucose in patients with type 2 diabetes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/45/21210?source=see_link&amp;anchor=H28#H28\">",
"       \"Treatment of hypertension in patients with diabetes mellitus\", section on 'Choice of antihypertensive agents'",
"      </a>",
"      .) In one study in rats, the enhancement of insulin sensitivity by",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/19/8505?source=see_link\">",
"       enalapril",
"      </a>",
"      was inhibited by a kinin antagonist whereas no change in insulin sensitivity was seen with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"       losartan",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19685/abstract/10\">",
"       10",
"      </a>",
"      ]. The effect of kinins may be mediated in part by increased blood flow to skeletal muscle, thereby promoting insulin delivery and glucose uptake.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Rationale for combined therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;With ACE inhibitors, the fall in angiotensin II leads to increased renin release, which partially returns angiotensin II levels toward baseline. In addition, ACE inhibitors only block the formation of angiotensin II that is mediated by angiotensin converting enzyme. There is evidence that alternative enzymatic pathways, particularly involving",
"    <strong>",
"     chymase",
"    </strong>",
"    , exist for the production of angiotensin II within the myocardium [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19685/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. A similar effect may occur in the blood vessels. In a mouse model, overexpression of vascular chymase leads to an elevation in blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19685/abstract/14\">",
"     14",
"    </a>",
"    ]. It remains to be proven that this effect is mediated by increased local production of angiotensin II.",
"   </p>",
"   <p>",
"    Because ACE inhibitors do not completely inhibit angiotensin II, it was suggested that combination therapy with both an ACE inhibitor and angiotensin receptor blocker might have synergistic effects. However, studies that employed combined therapy have shown an increase in adverse effects, cancer incidence, and mortality; thus, in the absence of a compelling indication, combination therapy is",
"    <strong>",
"     not",
"    </strong>",
"    recommended. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/2/18473?source=see_link&amp;anchor=H18#H18\">",
"     \"Major side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers\", section on 'Combination of ACE inhibitors and ARBs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL IMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although initial studies in a variety of disease states were performed with ACE inhibitors, it has been expected and in many cases demonstrated that similar benefits could be achieved with angiotensin receptor blockers.",
"   </p>",
"   <p>",
"    The following is a summary of the clinical settings in which these drugs have been used. The specific data are discussed in detail separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To slow the progression of proteinuric diabetic and nondiabetic chronic renal failure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=see_link\">",
"       \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/48/40714?source=see_link\">",
"       \"Treatment of diabetic nephropathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      To improve hemodynamics and survival in patients with heart failure due to systolic dysfunction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/45/16090?source=see_link\">",
"       \"ACE inhibitors in heart failure due to systolic dysfunction: Therapeutic use\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2680?source=see_link\">",
"       \"Angiotensin II receptor blockers in heart failure due to systolic dysfunction: Therapeutic use\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      To lower the blood pressure in patients with hypertension and also allow more rapid regression of left ventricular hypertrophy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/40/25224?source=see_link\">",
"       \"Renin-angiotensin system inhibition in the treatment of hypertension\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=see_link\">",
"       \"Clinical implications and treatment of left ventricular hypertrophy in hypertension\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It has also been suggested that ACE inhibitors and ARBs improve outcomes in patients at high risk for a cardiovascular event. However, it is likely that this beneficial effect is due to blood pressure reduction rather than a specific consequence of blockade of the renin-angiotensin system. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/29/36314?source=see_link&amp;anchor=H3#H3\">",
"     \"Choice of therapy in primary (essential) hypertension: Recommendations\", section on 'Importance of attained blood pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4851396\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Angiotensin II is an oligopeptide of eight amino acids, formed from its precursor, angiotensinogen by the enzymatic actions of renin and angiotensin converting enzyme. There are two well-described subtypes of angiotensin II receptors, designated AT1 and AT2, both of which have a high affinity for angiotensin II. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Mechanisms of action'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Inhibition of angiotensin II formation with an ACE inhibitor will diminish the activity of both the AT1 and AT2 receptor subtypes. In contrast, the angiotensin II receptor antagonists only diminish AT1 activity. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Receptor activation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Angiotensin converting enzyme is also a kininase; as a result, inhibiting this enzyme with an ACE inhibitor may lead to increased kinin levels, an effect not seen with the angiotensin II receptor antagonists. It is presumed that kinin accumulation accounts for the cough associated with ACE inhibitors. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Effect on kinins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Increased kinins may contribute to the blood pressure lowering effects of ACE inhibitors, as well as the effects of ACE inhibitors on improvements in endothelial function and insulin sensitivity. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Effect on kinins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The fall in angiotensin II induced by ACE inhibitors leads to increased renin release, which partially returns angiotensin II levels toward baseline. In addition, alternative enzymatic pathways, particularly involving chymase, may produce angiotensin II. This served as rationale to examine the effects of combined therapy with an ACE inhibitor and angiotensin receptor blocker. However, studies that employed combined therapy have shown an increase in adverse effects, cancer incidence, and mortality; thus, in the absence of a compelling indication, combination therapy is",
"      <strong>",
"       not",
"      </strong>",
"      recommended. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Rationale for combined therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although initial studies in a variety of disease states were performed with ACE inhibitors, it is expected, and in many cases demonstrated, that similar benefits can be achieved with angiotensin receptor blockers. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical implications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/1\">",
"      Matchar DB, McCrory DC, Orlando LA, et al. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med 2008; 148:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/2\">",
"      Timmermans PB, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/3\">",
"      Griendling KK, Lass&egrave;gue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 1996; 36:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/4\">",
"      Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med 1996; 334:1649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/5\">",
"      Tsutsumi K, Saavedra JM. Characterization and development of angiotensin II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol 1991; 261:R209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/6\">",
"      Grady EF, Sechi LA, Griffin CA, et al. Expression of AT2 receptors in the developing rat fetus. J Clin Invest 1991; 88:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/7\">",
"      Stoll M, Steckelings UM, Paul M, et al. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/8\">",
"      Hornig B, Kohler C, Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation 1997; 95:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/9\">",
"      Gainer JV, Morrow JD, Loveland A, et al. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 1998; 339:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/10\">",
"      Tomiyama H, Kushiro T, Abeta H, et al. Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor. Hypertension 1994; 23:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/11\">",
"      Chandrasekharan UM, Sanker S, Glynias MJ, et al. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science 1996; 271:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/12\">",
"      Urata H, Boehm KD, Philip A, et al. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993; 91:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/13\">",
"      Nishimura H, Hoffmann S, Baltatu O, et al. Angiotensin I converting enzyme and chymase in cardiovascular tissues. Kidney Int Suppl 1996; 55:S18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19685/abstract/14\">",
"      Ju H, Gros R, You X, et al. Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice. Proc Natl Acad Sci U S A 2001; 98:7469.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3854 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-22FFA76FCA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19685=[""].join("\n");
var outline_f19_14_19685=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4851396\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MECHANISMS OF ACTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Receptor activation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Effect on kinins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Rationale for combined therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL IMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4851396\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3854\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3854|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/23/9597\" title=\"figure 1\">",
"      Comparison of the actions of ACE inhibitors and ARBs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/45/16090?source=related_link\">",
"      ACE inhibitors in heart failure due to systolic dysfunction: Therapeutic use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/61/36825?source=related_link\">",
"      Actions of angiotensin II on the heart",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/39/2680?source=related_link\">",
"      Angiotensin II receptor blockers in heart failure due to systolic dysfunction: Therapeutic use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=related_link\">",
"      Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/25/13720?source=related_link\">",
"      Chapter 2B: Renin-angiotensin system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/29/36314?source=related_link\">",
"      Choice of therapy in primary (essential) hypertension: Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=related_link\">",
"      Clinical implications and treatment of left ventricular hypertrophy in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/2/18473?source=related_link\">",
"      Major side effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/40/25224?source=related_link\">",
"      Renin-angiotensin system inhibition in the treatment of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/48/40714?source=related_link\">",
"      Treatment of diabetic nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/45/21210?source=related_link\">",
"      Treatment of hypertension in patients with diabetes mellitus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_14_19686="Pleural mesothelial cell layer";
var content_f19_14_19686=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72742&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72742&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Pleural mesothelial cell layer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 289px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Both pleurae are lined by a continuous mesothelial cell layer. The mesothelial cell is a flat cell one to 4 &micro;m thick with a variable covering of microvilli (up to 3 &micro;m long).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of V Courtney Broaddus, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19686=[""].join("\n");
var outline_f19_14_19686=null;
var title_f19_14_19687="Retracted internal anal sphincter";
var content_f19_14_19687=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F76163&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F76163&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 493px\">",
"   <div class=\"ttl\">",
"    Endoanal ultrasound showing a retracted internal anal sphincter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 473px; height: 444px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The solid line represents the retracted internal anal sphincter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19687=[""].join("\n");
var outline_f19_14_19687=null;
var title_f19_14_19688="Orthopedic issues in myelomeningocele (spina bifida)";
var content_f19_14_19688=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Orthopedic issues in myelomeningocele (spina bifida)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/14/19688/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19688/contributors\">",
"     Vineeta T Swaroop, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19688/contributors\">",
"     Luciano Dias, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/14/19688/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19688/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19688/contributors\">",
"     William Phillips, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/14/19688/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19688/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/14/19688/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myelomeningocele, also known as spina bifida, leads to bowel, bladder, motor, and sensory paralysis below the level of the spinal lesion. Patients with myelomeningocele can have other lesions of the spinal cord (eg, diastematomyelia or hydromyelia) or structural abnormalities of the brain (eg, hydrocephalus), which can also compromise neurologic function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=see_link\">",
"     \"Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Orthopedic abnormalities in patients with myelomeningocele are caused by unbalanced muscle action around joints, paralysis, and decreased sensation in the lower extremities [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/1\">",
"     1",
"    </a>",
"    ]. Some of these problems are chronic or slowly progressive, and others may arise acutely because of progressive neurologic dysfunction, which might be caused by tethered cord or shunt malfunction.",
"   </p>",
"   <p>",
"    The main goal of orthopedic care of a patient with myelomeningocele is to correct deformities that may interfere with function. For some patients, functional goals may include ambulation using orthoses [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/2\">",
"     2",
"    </a>",
"    ]. In addition, the orthopedic surgeon must monitor spinal balance and deformity. Because acute changes in orthopedic problems can be caused by acute neurologic events, the orthopedic examination also helps to monitor the neurologic status of the patient.",
"   </p>",
"   <p>",
"    Orthopedic care of the child with myelomeningocele is made challenging by the presence of multiple medical comorbidities that must be taken into account in any treatment plan. These comorbidities include central nervous system involvement (eg, hydrocephalus), spinal cord complications (eg, syringomyelia and tethering), urinary tract complications (eg, bladder incontinence and renal dysfunction), bowel incontinence, insensate skin, and latex allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/3\">",
"     3",
"    </a>",
"    ]. For this reason, whenever possible, orthopedic care should be rendered as part of a multi-disciplinary team, working together with neurosurgery, urology, and physiatry.",
"   </p>",
"   <p>",
"    The evaluation and treatment of the common orthopedic problems that affect patients with myelomeningocele are discussed here. The management of their neurologic and urinary tract problems is discussed in a separate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26344?source=see_link\">",
"     \"Overview of the management of myelomeningocele (spina bifida)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15288?source=see_link\">",
"     \"Urinary tract complications of myelomeningocele (spina bifida)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     THE ORTHOPEDIC EXAMINATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation in the newborn or older child with myelomeningocele should include identification of the level of paralysis for each extremity by a manual muscle test performed by a skilled physical therapist, and should identify associated pathology, such as clubfoot or hip or knee contractures.",
"   </p>",
"   <p>",
"    The follow-up periodic orthopedic exam should include assessment of motor and sensory function, range of motion of the hip, knee, and ankle, spinal deformity, foot deformity, and integrity of skin. Changes should alert the clinician to the possibility of tethered cord. In addition, mobility and bracing needs should be addressed to ensure orthoses are appropriate, in good shape, and not causing any pressure points on the skin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Special considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician should be vigilant for several complications that are more common in patients with myelomeningocele as compared to healthy patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Latex allergy &mdash; Latex-free materials should be used for all patients to reduce the risk of developing latex allergy. Latex-free surgery is mandatory.",
"     </li>",
"     <li>",
"      Skin breakdown &mdash; Patients are at risk for skin breakdown because of decreased skin sensation and orthoses, so the skin should be inspected carefully and pressure points avoided.",
"     </li>",
"     <li>",
"      Pseudoarthrosis &mdash; Patients with myelomeningocele are at increased risk for pseudoarthroses (nonosseous union or \"false joint\") after attempted spinal fusion. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Spine'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Pathologic fractures &mdash; Patients are at risk for pathologic fractures because of joint contracture and decreased bone density (due to paralysis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      postsurgical immobilization, especially spica casting). Pathologic fractures are particularly prevalent in patients with a higher spinal cord level of neurologic involvement [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/1\">",
"       1",
"      </a>",
"      ]. Fractures in children with myelomeningocele can present with marked swelling and redness, and may be mistaken for osteomyelitis. Physeal fractures in children with myelomeningocele can compromise bone growth.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Ambulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ambulation is an important goal for many children with myelomeningocele, because it can provide physiological and psychological benefits, even if the child will later become nonambulatory. Therefore, one of the main tasks of the orthopedic surgeon is to evaluate and correct hip, knee, and foot deformities to maximize the patient's ability to ambulate with the aid of orthoses.",
"   </p>",
"   <p>",
"    Multiple factors affect the potential for ambulation in a given patient with myelomeningocele. Among these are the neurologic level of involvement, and the presence of hip deformity, scoliosis, or foot and ankle deformity, as well as age and obesity. One large study of 98 patients found that 20 of 21 patients with L5 or sacral level of involvement were able to ambulate moderate distances (\"community ambulators\") [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/4\">",
"     4",
"    </a>",
"    ]. In the same study, most patients with spinal involvement at L4 were also community ambulators, but patients with spinal involvement at L3 or above were mostly unable to ambulate except for very short distances within the home (nonfunctional ambulators).",
"   </p>",
"   <p>",
"    Another predictor for maintaining ambulation into adulthood is the strength of the quadriceps and hamstring muscles (of the anterior and posterior thigh, respectively), and iliopsoas muscles (involved in hip extension) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. In addition, one study found that achieving sitting balance was an important predictor of ambulatory potential in patients with higher spinal levels of neurologic involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Functional mobility scale",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Functional Mobility Scale (FMS) is a quick, clinically practical tool for distinguishing between groups of children with varying levels of disabilities, and provides a means for standardized communication between health professionals (",
"    <a class=\"graphic graphic_figure graphicRef79974 \" href=\"UTD.htm?25/14/25839\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/7\">",
"     7",
"    </a>",
"    ]. It was originally developed as a tool to describe functional mobility in children with cerebral palsy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/7\">",
"     7",
"    </a>",
"    ], and was subsequently applied to children with myelomeningocele [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/8\">",
"     8",
"    </a>",
"    ]. The score reflects the level of support needed (ranging from using a wheelchair or stroller to independent ambulation without walking aids) for mobility in each of three distances (5, 50, or 500 meters or yards, representing mobility in the home, at school, and in the community).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Gait analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Where available, computerized gait analysis is a valuable component of the comprehensive orthopedic evaluation of patients with myelomeningocele. It has been used as part of the evaluation of many manifestations of myelomeningocele, including hip",
"    <span class=\"nowrap\">",
"     subluxation/dislocation,",
"    </span>",
"    lower extremity contractures, and rotational abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. Gait analysis is especially useful in preoperative planning and in quantitatively assessing surgical results.",
"   </p>",
"   <p>",
"    Clinical evaluation of patients with myelomeningocele is complex, and involves multiple inter-related levels of deformity. Often, a patient's true functional status is different from the function that would be predicted based on the static clinical exam [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/11\">",
"     11",
"    </a>",
"    ]. This was demonstrated in a study examining crouched gait in patients with myelomeningocele [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/11\">",
"     11",
"    </a>",
"    ]. In these patients, computerized gait analysis revealed significantly greater amount of dynamic knee flexion during ambulation as compared to that measured on clinical exam.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SPINE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spinal deformity is the most frequently occurring orthopedic abnormality in patients with myelomeningocele [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/1\">",
"     1",
"    </a>",
"    ]. Spinal deformity may be congenital or acquired and can manifest as kyphosis, scoliosis, or lordosis. These deformities can cause back pain due to muscle fatigue or costopelvic impingement, or difficulty with ambulation and transfers due to the loss of trunk balance. They may also affect appearance, with adverse effects on self image and social interactions [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Scoliosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Progressive scoliosis in myelomeningocele can result from congenital vertebral malformations, muscular imbalance, and certain neurologic conditions (eg, syrinx or tethered cord). Scoliosis may develop gradually, in response to chronic neuromuscular dysfunction and skeletal growth, or rapidly, as a consequence of acute neurologic changes (such as tethered cord).",
"   </p>",
"   <p>",
"    The prevalence of scoliosis in patients with myelomeningocele correlates with the level of the spinal cord neurologic deficit. Rates vary from 5 percent in patients with sacral level deficits, to 70 percent in patients with L3 level deficits, to over 90 percent in patients with deficits at L1 or above [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/13\">",
"     13",
"    </a>",
"    ]. Thus, the clinician should be particularly vigilant for the development of scoliosis in patients with a high level of neurologic involvement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Nonoperative intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonoperative intervention for scoliosis consists of sitting supports, spinal orthoses, and functional strengthening programs designed to improve sitting balance and functional independence [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/13\">",
"     13",
"    </a>",
"    ]. This approach is usually employed in patients with spinal curves that are flexible and relatively mild (generally &lt;50&ordm;). The goal of using an orthosis is to support the trunk in a functional position and to control the curve during growth, possibly delaying the need for surgical stabilization [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/14\">",
"     14",
"    </a>",
"    ]. It is not used to correct the deformity.",
"   </p>",
"   <p>",
"    When an orthosis is prescribed for a patient with myelomeningocele, it is imperative to ensure proper fitting and to monitor regularly for skin complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Spinal fusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications for operative treatment of scoliosis in myelomeningocele are controversial. Most of the literature on surgical treatment of scoliosis in this population focuses on anatomic correction of spinal deformity as the primary outcome. Such studies demonstrate that surgery can achieve a significant reduction in curve magnitude [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. However, studies have failed to show corresponding improvement in functional outcomes, such as ambulation, motor skills, and activities of daily living [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/15,16,18\">",
"     15,16,18",
"    </a>",
"    ]. Furthermore, several studies suggest that ambulation may be more difficult following surgery.",
"   </p>",
"   <p>",
"    In contrast, for patients who are functionally limited to sitting preoperatively, surgical treatment may improve sitting balance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Kyphosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with myelomeningocele are at risk for developing progressive kyphosis, either lumbar or thoracic. Lumbar kyphosis may be present at birth, and commonly increases once the child begins to sit. Children with lumbar kyphosis tend to have more severe neurologic involvement, a higher prevalence of hydrocephalus, and a poorer quality of life as compared with children without lumbar kyphosis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/3\">",
"     3",
"    </a>",
"    ]. Older patients with lumbar kyphosis often develop compensatory thoracic lordosis; this is not seen at birth and is also progressive.",
"   </p>",
"   <p>",
"    These deformities do not respond well to nonsurgical intervention. Absolute criteria for surgical treatment are not well-defined, and the timing and type of surgery remain controversial. In our practice we consider surgical intervention for patients who have difficulty sitting or problems with skin breakdown that are attributable to the spinal deformity [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Surgical complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with myelomeningocele have increased risks for postoperative complications after scoliosis or kyphosis surgery, as compared with patients without myelomeningocele who undergo spine surgery. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Special considerations'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Complications encountered with frequency include implant problems (such as implant failure, dislocation, and pseudoarthrosis), infections, problems with anesthesia, and neurologic complications. In a series of 77 patients with spina bifida treated with spine surgery, implant problems developed in 29 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/19\">",
"     19",
"    </a>",
"    ]. Pseudoarthrosis rates as high as 76 percent have been reported, depending upon the surgical approach [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/3\">",
"     3",
"    </a>",
"    ]. Wound infections occur in up to one-half of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/3\">",
"     3",
"    </a>",
"    ]; the risk is increased by a concurrent urinary tract infection, which is common in this population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Surgical decision making",
"    </span>",
"    &nbsp;&mdash;&nbsp;When making decisions about surgery, the surgeon, patient, and family should recognize the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although spinal fusion can reliably reduce curve magnitude, it has not been shown to improve walking ability in ambulatory patients, and may result in decreased ambulatory function. Spinal fusion does not appear to change motor skills or activities of daily living. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Spinal fusion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with myelomeningocele have increased risks for implant failure, pressure sores, wound infections, and pseudoarthrosis compared to patients with scoliosis but without myelomeningocele. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Surgical complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A fused spine may interfere with bending for perineal care and self catheterization, particularly for girls. Most children with myelomeningocele have their spinal fusions extended to the pelvis. This loss of motion may increase the risk of pressure sores.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     HIP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hip deformity in patients with myelomeningocele results from muscle imbalance and paralysis around the hip joint [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/1\">",
"     1",
"    </a>",
"    ]. Hip deformity may present as contracture, subluxation, or dislocation. If not treated properly, contractures can lead to pelvic obliquity and compensatory spinal abnormality [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the past, surgical treatment focused on reducing paralytic hip dislocations. However, current treatment goals, based on studies of functional outcomes, focus on maintaining hip range of motion, and surgery is usually performed only to release contractures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Previous approaches to dislocation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the earlier studies reporting on the results of major hip reconstruction in myelomeningocele patients focused on the outcome of hip reduction (determined radiologically). However, subsequent studies focusing on functional outcomes suggested that this type of surgical intervention did not improve the ability to ambulate, the need for bracing, or decrease pain [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/10,20-22\">",
"     10,20-22",
"    </a>",
"    ]. Moreover, a high rate of complications was noted in surgically treated patients, including loss of motion and pathologic fractures, which further compromised ambulation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Current approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of these considerations, we do not recommend extensive surgery to reduce hip dislocations in patients with myelomeningocele [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/21\">",
"     21",
"    </a>",
"    ]. It is now recognized that the most important factor in determining ability to walk is level of neural involvement and not the status of the hip [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/10,20-23\">",
"     10,20-23",
"    </a>",
"    ]. Consequently, current management emphasizes preservation of muscle strength, specifically of the iliopsoas and the quadriceps. Treatment goals should include maintaining a level pelvis and free motion of the hips rather than radiographic reduction of the hip [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/21\">",
"     21",
"    </a>",
"    ]. The treating surgeon must counsel patients and their families appropriately so that the goals of surgery are clearly understood. In our practice, the only recommended surgical treatment for hip dislocations is contracture release [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/10,21\">",
"     10,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A possible exception is the rare sacral-level patient with a dislocated hip who walks without support. These patients may demonstrate an increased lurch due to the loss of a fulcrum, resulting from the dislocated hip. Consequently, these specific patients may benefit from surgical reduction, but outcomes of surgery in this subgroup of patients have not been described.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ROTATIONAL ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both ambulatory and nonambulatory patients with myelomeningocele frequently develop torsional deformities of the lower extremities.",
"   </p>",
"   <p>",
"    Torsion is defined as twisting or rotation of a bone about its long axis. Normal healthy infants have some degree of femoral torsion at birth, and this usually decreases gradually as the child grows. However, in patients with myelomeningocele, the torsion often fails to decrease normally with growth because of abnormal gait and activity levels [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/1\">",
"     1",
"    </a>",
"    ]. In patients with myelomeningocele, tibial torsion is even more common than femoral torsion. Tibial torsion can be either external, which is caused by muscle imbalance, or internal, which is congenital.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Nonambulatory patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;For nonambulatory patients, torsional deformities do not interfere with function, and intervention is not usually indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Ambulatory patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;For ambulatory patients, torsional deformities often interfere with ambulatory function, and should be addressed.",
"   </p>",
"   <p>",
"    Initially, most of these patients can be treated conservatively with orthoses. The role of the orthopedic surgeon is to minimize bracing requirements while achieving as normal a gait as possible [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest rotational osteotomy for the many patients who go on to develop severe labored gait, difficulty with orthotic fitting (resulting in skin ulceration), and pain [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/9\">",
"     9",
"    </a>",
"    ]. In this case, the treating surgeon should carefully assess the patient's gait to determine the extent of deformity correction needed before planning surgery, using computerized gait analysis, if available [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/2\">",
"     2",
"    </a>",
"    ]. In addition, it is essential to examine the patient's entire lower extremity, paying particular attention to the hindfoot, because patients with external tibial torsion often have associated hindfoot valgus. Often, both deformities require treatment in order to achieve a successful result. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Gait analysis'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H21\">",
"     'Foot and ankle'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Among patients treated with lower extremity osteotomies, 80 to 90 percent have good functional outcomes, as measured by gait parameters and range of motion [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Derotation osteotomy may also delay or prevent degenerative changes that may occur in patients with excessive external tibial torsion [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/9\">",
"     9",
"    </a>",
"    ]. As an example, one study found increased valgus knee stress in each of eight patients with external tibial torsion, and this improved after derotational osteotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/9\">",
"     9",
"    </a>",
"    ]. These potential benefits must be balanced with the risks for surgical complications. Patients with myelomeningocele have increased risks for delayed union (especially in tibial osteotomies), and wound infection [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Special considerations'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     FOOT AND ANKLE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Foot deformities are present in 80 to 95 percent of patients affected by myelomeningocele [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/1\">",
"     1",
"    </a>",
"    ]. The spectrum of foot deformities includes clubfoot, calcaneus, equinus, varus, valgus, and vertical talus [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/26\">",
"     26",
"    </a>",
"    ]. Intrauterine paralysis is a major contributing cause of congenital foot deformity and is exacerbated by increased intrauterine pressure and malposition [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Foot deformities can interfere with effective bracing that may be needed for ambulation. The deformities can also cause pressure sores, difficulty with shoe wear, and can be a cosmetic problem. The goal of orthopedic treatment is a plantigrade, flexible, braceable foot on which a shoe can be worn to allow ambulation.",
"   </p>",
"   <p>",
"    The treatment principles for foot deformities can be stratified by severity and type of deformity. Deformities more likely to respond favorably to passive manipulation include equinus and mild positional clubfoot. Infants with these and other foot deformities should undergo a trial of gentle passive manipulation, taking great care to avoid skin complications [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/2\">",
"     2",
"    </a>",
"    ]. The orthopedic surgeon must communicate to the family that even if early correction is possible, recurrence is common, and future need for surgery is still a possibility. Surgery is typically performed around one year of age in order to facilitate brace wear, standing, and ambulation.",
"   </p>",
"   <p>",
"    Virtually all children with myelomeningocele have absent or limited sensation on the plantar aspect of their feet. The parents should be counseled to not let their child go barefoot. Walking in a swimming pool without foot protection is a common cause of sores.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Clubfoot",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clubfoot (talipes equinovarus) is present in about 32 percent of patients with myelomeningocele and nearly always requires surgical correction (",
"    <a class=\"graphic graphic_picture graphicRef63390 \" href=\"UTD.htm?6/44/6850\">",
"     picture 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/1\">",
"     1",
"    </a>",
"    ]. Mild positional clubfoot in an infant may be addressed with passive manipulation, as described above.",
"   </p>",
"   <p>",
"    The clubfoot deformity is often rigid, requires extensive surgery to correct, and has a propensity to recur. Postoperative casting must be carried out judiciously with regular inspection of the skin to prevent wound problems and pressure sores. After casting, bracing is required indefinitely.",
"   </p>",
"   <p>",
"    The Ponseti method of clubfoot treatment with serial manipulation and casting has been attempted in patients with myelomeningocele. No long-term outcome data are available. However, one study reports successful initial reduction in 96 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/27\">",
"     27",
"    </a>",
"    ]. Sixty-eight percent of these experienced relapse and required retreatment, but most of these were successfully treated without needing extensive soft-tissue release surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Calcaneus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcaneus is seen in about 35 percent of patients with myelomeningocele and is particularly common in those with L4 to L5 level involvement (",
"    <a class=\"graphic graphic_picture graphicRef80659 \" href=\"UTD.htm?16/50/17199\">",
"     picture 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/1\">",
"     1",
"    </a>",
"    ]. It results from muscle imbalance between the active dorsiflexors and paralyzed plantar flexors of the ankle, and causes difficulty with bracing and shoe wear.",
"   </p>",
"   <p>",
"    One study reported a good result in 82 percent of calcaneus feet treated with anterior or anterolateral soft tissue release [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Talus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vertical talus (rocker bottom foot) is present in about 10 percent of patients with myelomeningocele, and usually requires surgical correction (",
"    <a class=\"graphic graphic_picture graphicRef66767 \" href=\"UTD.htm?43/5/44126\">",
"     picture 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Cavovarus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another pattern of foot deformity seen in patients with myelomeningocele is cavovarus (",
"    <a class=\"graphic graphic_picture graphicRef72266 \" href=\"UTD.htm?28/60/29636\">",
"     picture 4",
"    </a>",
"    ). This deformity is characterized by an elevated longitudinal arch (cavus). An inverted heel (varus) then results from the muscle imbalance between the posterior tibialis and the peroneal muscles. When the cavovarus is rigid, it often causes skin breakdown, difficulty with bracing, and problems with ambulation. Rapid development of progressive cavovarus can be caused by a tethered cord and should prompt a thorough neurologic evaluation.",
"   </p>",
"   <p>",
"    A surgical technique combining joint-sparing osteotomies with appropriate soft-tissue releases has shown promise in patients with myelomeningocele and cavovarus deformities [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/29\">",
"     29",
"    </a>",
"    ]. Fusions generally should be avoided whenever possible in this patient population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Valgus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ankle valgus is another problem commonly seen in ambulatory patients with spina bifida (",
"    <a class=\"graphic graphic_picture graphicRef61991 \" href=\"UTD.htm?41/8/42116\">",
"     picture 5",
"    </a>",
"    ). This can lead to skin irritation and breakdown over the medial malleolus due to excessive pressure against the orthosis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19688/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical treatment for valgus ankle varies depending on the precise anatomical location of the deformity, which can arise from the distal tibia, subtalar joint, or both. Treatment options include distal tibia osteotomy, hemiepiphysiodesis of the distal tibia, or medial displacement osteotomy of the calcaneus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     ORTHOSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children with myelomeningocele, orthoses are used to maintain alignment, prevent deformity, correct flexible deformities, facilitate independent mobility, and protect the insensate limb.",
"   </p>",
"   <p>",
"    In children with thoracic and high lumbar level involvement, orthoses are used for upright weight bearing and mobility. Often these children have functional hip flexors and adductors, but poor quadriceps function. Hence, the orthoses need to cross and control the hip in order to maintain the trunk over the pelvis and lower limbs. Examples are hip-knee-ankle-foot orthoses or reciprocating-gait orthoses (",
"    <a class=\"graphic graphic_picture graphicRef80993 \" href=\"UTD.htm?9/4/9285\">",
"     picture 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Children with low lumbar and sacral level involvement often also require orthoses due to absent hip extensors and abductors, as well as ankle plantar- and dorsi-flexors. Often they require a knee-ankle-foot orthosis or an ankle-foot orthosis (",
"    <a class=\"graphic graphic_picture graphicRef80327 \" href=\"UTD.htm?5/25/5523\">",
"     picture 7",
"    </a>",
"    ) in order to maximize gait efficiency and control the position of the foot.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main goal of orthopedic care is to maximize function and mobility, and minimize deformity and pain.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Orthopedic abnormalities in patients with myelomeningocele are caused by unbalanced muscle action around joints, paralysis, and decreased sensation in the lower extremities. These deficits cause problems in the spine (scoliosis and kyphosis), hip (dislocation and contractures), rotational abnormalities of the leg (femoral or tibial torsion), foot, and ankle (clubfoot and other deformities). Each of these deformities may contribute to functional problems with ambulation or other activities of daily living.",
"     </li>",
"     <li>",
"      Patients with myelomeningocele have increased risks for wound infections, pathologic fractures, nonunion after orthopedic surgery, as well as latex allergy and skin breakdown. These considerations should inform surgical decision-making and routine care. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Special considerations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rapid development of an orthopedic problem, including scoliosis and foot deformities, may be caused by an acute neurologic pathology (eg, tethered cord or shunt malfunction) and should prompt a thorough neurologic evaluation. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26344?source=see_link\">",
"       \"Overview of the management of myelomeningocele (spina bifida)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Scoliosis treatment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with myelomeningocele and mild to moderate scoliosis (a flexible curve &lt;50&ordm;), we recommend nonoperative intervention rather than surgery (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Nonoperative intervention consists of sitting supports, spinal orthoses, and functional strengthening programs designed to improve sitting balance and functional independence. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Nonoperative intervention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The optimal management for ambulatory patients with more severe scoliosis or kyphosis is controversial. Although spinal fusion can reliably reduce curve magnitude, it has not been shown to improve walking ability, motor skills, or activities of daily living in ambulatory patients, and in some cases, can result in decreased ambulatory ability. Thus, surgical decisions should be made on a case-by-case basis, after review of the potential benefits, risks, and uncertainties with the patient and family. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Spinal fusion'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Surgical decision making'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For nonambulatory patients with severe scoliosis that interferes with function (impaired sitting balance or problems with skin breakdown), we suggest surgical treatment (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Surgical treatment may improve sitting balance in this group of patients. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Surgical decision making'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Hip dislocations",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with hip dislocations and neurologic deficits above the sacrum, we recommend AGAINST operative reduction (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). For such patients, surgery to reduce the dislocation does not improve the ability to ambulate, the need for bracing, or decrease pain. These patients may benefit from surgical release of contractures as needed to maintain a level pelvis and free motion of the hips. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Current approach'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Femoral and tibial torsion",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ambulatory patients with femoral or tibial torsion causing functional problems (severe labored gait, difficulty with orthotic fitting and pain) should be treated with rotational osteotomy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Ambulatory patients'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Foot deformities",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients with myelomeningocele have foot and ankle deformities, including clubfoot, calcaneus, equinus, varus, valgus, and vertical talus. Equinus, calcaneus, and mild positional clubfoot may respond to conservative management with passive manipulation. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Foot and ankle'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clubfoot deformities are often rigid, and most require surgical correction. Recurrence after surgery is common. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Clubfoot'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/1\">",
"      Westcott MA, Dynes MC, Remer EM, et al. Congenital and acquired orthopedic abnormalities in patients with myelomeningocele. Radiographics 1992; 12:1155.",
"     </a>",
"    </li>",
"    <li>",
"     Neuromuscular disorders. In: Tachdjian's Pediatric orthopedics, Herring, J (Ed), Saunders Elsevier, Philadelphia 2008. p.1405.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/3\">",
"      Guille JT, Sarwark JF, Sherk HH, Kumar SJ. Congenital and developmental deformities of the spine in children with myelomeningocele. J Am Acad Orthop Surg 2006; 14:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/4\">",
"      Asher M, Olson J. Factors affecting the ambulatory status of patients with spina bifida cystica. J Bone Joint Surg Am 1983; 65:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/5\">",
"      Seitzberg A, Lind M, Biering-S&oslash;rensen F. Ambulation in adults with myelomeningocele. Is it possible to predict the level of ambulation in early life? Childs Nerv Syst 2008; 24:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/6\">",
"      Swank M, Dias LS. Walking ability in spina bifida patients: a model for predicting future ambulatory status based on sitting balance and motor level. J Pediatr Orthop 1994; 14:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/7\">",
"      Graham HK, Harvey A, Rodda J, et al. The Functional Mobility Scale (FMS). J Pediatr Orthop 2004; 24:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/8\">",
"      Battibugli S, Gryfakis N, Dias L, et al. Functional gait comparison between children with myelomeningocele: shunt versus no shunt. Dev Med Child Neurol 2007; 49:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/9\">",
"      Dunteman RC, Vankoski SJ, Dias LS. Internal derotation osteotomy of the tibia: pre- and postoperative gait analysis in persons with high sacral myelomeningocele. J Pediatr Orthop 2000; 20:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/10\">",
"      Gabrieli AP, Vankoski SJ, Dias LS, et al. Gait analysis in low lumbar myelomeningocele patients with unilateral hip dislocation or subluxation. J Pediatr Orthop 2003; 23:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/11\">",
"      Moen T, Gryfakis N, Dias L, Lemke L. Crouched gait in myelomeningocele: a comparison between the degree of knee flexion contracture in the clinical examination and during gait. J Pediatr Orthop 2005; 25:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/12\">",
"      Vankoski S, Moore C, Statler KD, et al. The influence of forearm crutches on pelvic and hip kinematics in children with myelomeningocele: don't throw away the crutches. Dev Med Child Neurol 1997; 39:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/13\">",
"      Berven S, Bradford DS. Neuromuscular scoliosis: causes of deformity and principles for evaluation and management. Semin Neurol 2002; 22:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/14\">",
"      McCarthy RE. Management of neuromuscular scoliosis. Orthop Clin North Am 1999; 30:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/15\">",
"      M&uuml;ller EB, Nordwall A, von Wendt L. Influence of surgical treatment of scoliosis in children with spina bifida on ambulation and motoric skills. Acta Paediatr 1992; 81:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/16\">",
"      Schoenmakers MA, Gulmans VA, Gooskens RH, et al. Spinal fusion in children with spina bifida: influence on ambulation level and functional abilities. Eur Spine J 2005; 14:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/17\">",
"      Wai EK, Young NL, Feldman BM, et al. The relationship between function, self-perception, and spinal deformity: Implications for treatment of scoliosis in children with spina bifida. J Pediatr Orthop 2005; 25:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/18\">",
"      Mazur J, Menelaus MB, Dickens DR, Doig WG. Efficacy of surgical management for scoliosis in myelomeningocele: correction of deformity and alteration of functional status. J Pediatr Orthop 1986; 6:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/19\">",
"      Geiger F, Parsch D, Carstens C. Complications of scoliosis surgery in children with myelomeningocele. Eur Spine J 1999; 8:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/20\">",
"      Sherk HH, Ames MD. Functional results of iliopsoas transfer in myelomeningocele hip dislocations. Clin Orthop Relat Res 1978; :181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/21\">",
"      Feiwell E, Sakai D, Blatt T. The effect of hip reduction on function in patients with myelomeningocele. Potential gains and hazards of surgical treatment. J Bone Joint Surg Am 1978; 60:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/22\">",
"      Sherk HH, Uppal GS, Lane G, Melchionni J. Treatment versus non-treatment of hip dislocations in ambulatory patients with myelomeningocele. Dev Med Child Neurol 1991; 33:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/23\">",
"      Feiwell E. Surgery of the hip in myelomeningocele as related to adult goals. Clin Orthop Relat Res 1980; :87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/24\">",
"      Dias LS, Jasty MJ, Collins P. Rotational deformities of the lower limb in myelomeningocele. Evaluation and treatment. J Bone Joint Surg Am 1984; 66:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/25\">",
"      Fraser RK, Menelaus MB. The management of tibial torsion in patients with spina bifida. J Bone Joint Surg Br 1993; 75:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/26\">",
"      Frawley PA, Broughton NS, Menelaus MB. Incidence and type of hindfoot deformities in patients with low-level spina bifida. J Pediatr Orthop 1998; 18:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/27\">",
"      Gerlach DJ, Gurnett CA, Limpaphayom N, et al. Early results of the Ponseti method for the treatment of clubfoot associated with myelomeningocele. J Bone Joint Surg Am 2009; 91:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/28\">",
"      Rodrigues RC, Dias LS. Calcaneus deformity in spina bifida: results of anterolateral release. J Pediatr Orthop 1992; 12:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19688/abstract/29\">",
"      Mubarak SJ, Van Valin SE. Osteotomies of the foot for cavus deformities in children. J Pediatr Orthop 2009; 29:294.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6211 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-4C9EBFD82E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19688=[""].join("\n");
var outline_f19_14_19688=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      THE ORTHOPEDIC EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Special considerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Ambulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Functional mobility scale",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Gait analysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SPINE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Scoliosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Nonoperative intervention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Spinal fusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Kyphosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Surgical complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Surgical decision making",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      HIP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Previous approaches to dislocation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Current approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ROTATIONAL ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Nonambulatory patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Ambulatory patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      FOOT AND ANKLE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Clubfoot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Calcaneus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Talus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Cavovarus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Valgus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      ORTHOSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Scoliosis treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Hip dislocations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Femoral and tibial torsion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Foot deformities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6211\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6211|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/14/25839\" title=\"figure 1\">",
"      Functional mobility scale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6211|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/44/6850\" title=\"picture 1\">",
"      Clubfoot infant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/50/17199\" title=\"picture 2\">",
"      Calcaneus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/5/44126\" title=\"picture 3\">",
"      Vertical talus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/60/29636\" title=\"picture 4\">",
"      Cavovarus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/8/42116\" title=\"picture 5\">",
"      Ankle valgus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/4/9285\" title=\"picture 6\">",
"      Recipro gait orthosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/25/5523\" title=\"picture 7\">",
"      Ankle foot orthosis1",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26344?source=related_link\">",
"      Overview of the management of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=related_link\">",
"      Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15288?source=related_link\">",
"      Urinary tract complications of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_14_19689="SLE Membranous";
var content_f19_14_19689=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F56549&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F56549&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light micrograph showing membranous lupus nephritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of membranous lupus nephritis. The changes are similar to those in any form of membranous nephropathy with diffuse thickening of the glomerular capillary wall being the major abnormality (short arrows). Focal areas of mesangial expansion and hypercellularity (long arrows) are the only findings suggestive of an underlying disease such as lupus, although they can also be seen in idiopathic membranous nephropathy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a normal glomerulus. There are only 1 or 2 cells per capillary tuft, the capillary lumens are open, the thickness of the glomerular capillary wall (long arrow) is similar to that of the tubular basement membranes (short arrow), and the mesangial cells and mesangial matrix are located in the central or stalk regions of the tuft (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut G Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19689=[""].join("\n");
var outline_f19_14_19689=null;
var title_f19_14_19690="Mannose-binding lectin deficiency";
var content_f19_14_19690=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mannose-binding lectin deficiency",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/14/19690/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19690/contributors\">",
"     Maarten W Bronkhorst, MD, FEBS, FRCS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19690/contributors\">",
"     Lee H Bouwman, MD, PhD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/14/19690/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19690/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/14/19690/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/14/19690/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/14/19690/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mannose-binding lectin (MBL), also known as mannan-binding protein (MBP), is a protein that is involved in complement activation via the lectin pathway (",
"    <a class=\"graphic graphic_figure graphicRef60513 \" href=\"UTD.htm?34/45/35550\">",
"     figure 1",
"    </a>",
"    ). The complement system provides immediate defense against infection and has proinflammatory effects.",
"   </p>",
"   <p>",
"    MBL deficiency is defined as a serum level &lt;500",
"    <span class=\"nowrap\">",
"     ng/mL.",
"    </span>",
"    It is a laboratory finding that does not necessarily equate to a clinical disorder. MBL deficiency is associated with a large and heterogeneous group of disease processes. However, subnormal levels are also found in healthy people. To date, there is no consensus on the clinical relevance of MBL deficiency or its treatment.",
"   </p>",
"   <p>",
"    This topic will discuss the genetics, epidemiology, diagnosis, and therapy of MBL deficiency and will review diseases associated with both low and high levels of MBL. Genetic defects and polymorphisms of the MBL2 gene, the function of the MBL protein, and other disorders of the complement system are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12420?source=see_link\">",
"     \"Mannose-binding lectin\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/58/42920?source=see_link\">",
"     \"Inherited disorders of the complement system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/54/29542?source=see_link\">",
"     \"Acquired disorders of the complement system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficiency of MBL was defined in the largest series as a serum level &lt;500",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    measured within 48 hours of admission in patients hospitalized with pneumococcal infection [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/1\">",
"     1",
"    </a>",
"    ]. MBL deficiency is generally defined as a serum level &lt;500",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    or MBL activity below 200",
"    <span class=\"nowrap\">",
"     U/mL,",
"    </span>",
"    depending upon the assay used. However, physiologically relevant MBL levels may vary depending upon the associated disease state, with reported cutoffs ranging from 100 to 1000",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. In addition, serum concentrations of lectin pathway components, including MBL, vary depending upon age of the patient [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/6\">",
"     6",
"    </a>",
"    ]. Some groups have defined partial MBL deficiency as an MBL level of &gt;50 to 1000",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    and severe MBL deficiency as an MBL level of &le;50",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. MBL deficiency was defined as &lt;100",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    in a study of 22 children with selective antibody deficiency and MBL deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persons with mutations of both MBL2 alleles constitute between 1 and 65 percent (median 5 percent) of the population, depending upon the ethnic group [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Heterozygosity, or the presence of mutations in one MBL2 allele, is found in more than 30 percent of the population in most ethnic groups evaluated. Thus, up to 40 percent of most populations may have mutations in one or both MBL2 alleles [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12420?source=see_link&amp;anchor=H2#H2\">",
"     \"Mannose-binding lectin\", section on 'The MBL gene'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal or wild-type MBL allele is called allele A. To date, three point mutations have been identified, all in exon 1, designated alleles B, C, and D. As a group, the variant alleles are also called allele or genotype 0. There is an autosomal pattern of inheritance. However, the MBL serum phenotype is gene dose dependent, so inheritance cannot be defined as dominant or recessive. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Genotype/phenotype correlation'",
"    </a>",
"    below.) The level of functional MBL is decreased by as much as 90 percent even in heterozygotes. The effect of the D allele in heterozygotes is less dramatic than that of the B or C alleles. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12420?source=see_link&amp;anchor=H2#H2\">",
"     \"Mannose-binding lectin\", section on 'The MBL gene'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The B variant mutation occurs at a gene frequency of about 25 percent in Eurasian populations, but is virtually absent in sub-Saharan West Africa [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/15\">",
"     15",
"    </a>",
"    ]. The C variant is absent among Asians and American Indians, is rare among Caucasians, but is commonly seen in sub-Saharan African populations, with a frequency of 50 to 60 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/16\">",
"     16",
"    </a>",
"    ]. The D allele occurs with lower frequency than the B or C alleles and appears to be confined to Caucasians and northern East-African populations [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to the three mutations in exon 1, there are several other single nucleotide polymorphisms (SNPs) located in the MBL2 promoter region that are associated with decreased MBL serum concentration (variants",
"    <span class=\"nowrap\">",
"     H/L,",
"    </span>",
"    <span class=\"nowrap\">",
"     Y/X,",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     P/Q).",
"    </span>",
"    There are many possible combinations of exon1 mutations and promoter SNPs. However, only seven common haplotypes are found in humans:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Promoter haplotypes associated with a normal (\"wild-type\") exon 1 haplotype include HYPA, LYPA, LYQA, and LXPA, which have high, high-intermediate, intermediate, and low promoter activity, respectively",
"     </li>",
"     <li>",
"      The genotype 0 variant haplotypes include HYPD, LYPB, and LYQC",
"     </li>",
"     <li>",
"      The LXPA haplotype is seen in 24 percent of Caucasians, and as such is the most common cause of MBL deficiency in this group (either LXPA homozygous or LXPA plus a variant haplotype)",
"     </li>",
"     <li>",
"      LYPB is the most common variant haplotype in Asians and Caucasians (22 and 12 percent, respectively), but is rare in Africans [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/18\">",
"       18",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      LYQC is the haplotype most often found in Africans (24 percent), but is uncommon in Caucasians and Asians",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    High worldwide prevalence of MBL deficiency or low protein-producing alleles is caused exclusively by human migration and genetic drift, indicating that MBL2 variation does not have a strong effect on population fitness [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/19\">",
"     19",
"    </a>",
"    ]. However, other data suggest that MBL deficiency may have an evolutionary advantage. As an example, high MBL production (normal genotype A) is associated with preterm birth, compared with intermediate MBL production (variant genotype B) and low MBL production (variant genotype C) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Genotype/phenotype correlation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of individuals with low MBL levels appear to be unaffected [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/21\">",
"     21",
"    </a>",
"    ]. The immune system has redundancies. In most cases, increased susceptibility to infection with MBL deficiency appears to arise when there are other concomitant factors causing immunocompromise [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/18\">",
"     18",
"    </a>",
"    ]. However, low levels of MBL are associated with poorer outcomes with certain infections even in immunocompetent individuals. Clinically relevant levels in the context of the regulatory role of MBL in autoimmune disorders are not as clearly defined.",
"   </p>",
"   <p>",
"    Normal homozygotes (genotype",
"    <span class=\"nowrap\">",
"     A/A)",
"    </span>",
"    generally have MBL levels above 1000",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    with levels up to 10,000",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/18,22\">",
"     18,22",
"    </a>",
"    ]. Heterozygous individuals",
"    <span class=\"nowrap\">",
"     (A/0",
"    </span>",
"    genotype) have about one-sixth to one-eighth the normal functional level of MBL, with levels generally ranging from 500 to 1000",
"    <span class=\"nowrap\">",
"     ng/mL.",
"    </span>",
"    Individuals homozygous for variant MBL2 alleles (genotype",
"    <span class=\"nowrap\">",
"     0/0)",
"    </span>",
"    usually have levels &lt;50",
"    <span class=\"nowrap\">",
"     ng/mL.",
"    </span>",
"    One patient was reported with undetectable MBL (&lt;20",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/23\">",
"     23",
"    </a>",
"    ]. Similar levels are seen in patients with the promoter variants LXP and normal A allele (LXPA haplotype) on one gene and the B, C, or D allele on the other. The combination of mutations in exon 1 and the promoter region results in a dramatic variation in MBL concentrations of up to 1000-fold in apparently healthy individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Physiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Circulating MBL in the newborn, measured in umbilical cord blood, is of fetal, not maternal, origin [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/24\">",
"     24",
"    </a>",
"    ]. Levels in term infants are two-thirds that of their mothers, and reach adult levels in about one month.",
"   </p>",
"   <p>",
"    Plasma levels of MBL are stable over time in individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/25\">",
"     25",
"    </a>",
"    ]. No circadian variation is described. Physical exercise does not affect levels [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/26\">",
"     26",
"    </a>",
"    ]. MBL is reported to behave like an acute phase reactant, although levels increase only about 1.5-fold one to two weeks after the inciting event and show variation between individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/27\">",
"     27",
"    </a>",
"    ]. Persons with low levels of MBL do not reach serum levels of wild-type individuals during an acute phase response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many individuals suffer no sequelae from MBL deficiency due to different polymorphisms of the MBL2 gene and its promoter, because of redundancies in the immune system. Increased susceptibility to infection is generally seen in patients with MBL deficiency when additional factors that compromise the immune system are present. However, some individuals with insufficient serum MBL levels who are otherwise immunocompetent are more likely to have recurrent infectious disease and poorer outcomes from infection. It is possible that another part of the immune system that overlaps with MBL is functioning at the low end of normal in these individuals, and this lower level of function is not sufficient to make up for the MBL deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of MBL in autoimmune disorders is less clear-cut. Overall, individuals generally benefit from normal levels of MBL. However, in some cases low levels appear to be advantageous [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/29\">",
"     29",
"    </a>",
"    ]. This dual effect is called heterosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The innate immune system constitutes the principal defense against infection when the adaptive immune response is either immature or compromised. In certain individuals, deficiency of MBL is associated with an increased frequency of pyogenic infections, especially encapsulated bacteria, due to defective opsonization. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/37/16986?source=see_link&amp;anchor=H9421023#H9421023\">",
"     \"An overview of the innate immune system\", section on 'Collectins'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     In immunocompromised hosts",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increased incidence of infectious disease is seen in immunocompromised individuals and immunologically immature neonates and infants who are also MBL-deficient. Patients may be immunocompromised for a number of reasons, including immunologic immaturity, acute critical illness, chronic disease, chemotherapy, transplantation, major surgery, and other immunodeficiencies.",
"   </p>",
"   <p>",
"    Examples of the association between MBL deficiency and increased risk of infection in immunocompromised hosts are provided below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Failure to opsonize Saccharomyces cerevisiae was first described in an infant with severe recurrent infections, diarrhea, and failure to thrive [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/30\">",
"       30",
"      </a>",
"      ]. This defect was later reported in other young children with frequent unexplained infections, chronic diarrhea, recurrent otitis media, and atopic disease [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/30-34\">",
"       30-34",
"      </a>",
"      ]. MBL deficiency underlying this opsonization defect was initially recognized in 10 patients ranging in age from nine months to nine years (six presented with recurrent upper respiratory tract infections, two with severe diarrhea and failure to thrive, and two with fever of unknown origin) [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A systematic review of MBL and infection risk in newborns found that low MBL levels were associated with increased rates of culture-confirmed sepsis in three out of five phenotypic studies [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/35\">",
"       35",
"      </a>",
"      ]. However, results were contradictory in the six MBL2 genotypic studies.",
"     </li>",
"     <li>",
"      In a prospective study, children aged 6 to 17 months with MBL insufficiency, based upon genotype, were found to have a two-fold increased relative risk (95% CI, 1.41-3.06) of acute respiratory tract infection compared with MBL-sufficient children [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/36\">",
"       36",
"      </a>",
"      ]. No difference was seen in children less than six months of age and those 18 to 23 months of age. This is in contrast to a subsequent study of infants followed from birth to one year of age, in which the outcome of interest was respiratory symptoms (cough and wheeze), rather than respiratory infection [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/37\">",
"       37",
"      </a>",
"      ]. This study found that infants in the upper third of MBL levels who also had a mother",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      father with asthma were at greatest risk for severe respiratory symptoms and wheezing, followed by those in the lowest third, compared with infants in the middle third.",
"     </li>",
"     <li>",
"      In a retrospective series of 55 children with MBL deficiency, 40 percent had concomitant selective antibody deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/10\">",
"       10",
"      </a>",
"      ]. These patients had more frequent episodes of otitis media, pneumonia, and sepsis than the children with MBL deficiency alone. In addition, they were more likely to receive prophylactic antibiotics or immune globulin replacement therapy.",
"     </li>",
"     <li>",
"      In most studies of critically ill patients admitted to the ICU, MBL variant genotypes and low MBL levels are associated with increased risk of sepsis, septic shock, and fatal outcome [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/38-40\">",
"       38-40",
"      </a>",
"      ]. As an example, ICU patients who were homozygous for the MBL2 variant genotype",
"      <span class=\"nowrap\">",
"       (O/O)",
"      </span>",
"      had an increased frequency of Gram-positive bacterial infection and the highest adjusted mortality rate after discharge from the ICU, followed by those homozygous for the normal MBL2 allele",
"      <span class=\"nowrap\">",
"       (A/A),",
"      </span>",
"      whereas heterozygous",
"      <span class=\"nowrap\">",
"       A/O",
"      </span>",
"      patients had the most favorable outcome [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/41\">",
"       41",
"      </a>",
"      ]. However, in a small series of patients with meningococcal septic shock, the two patients with MBL deficiency had decreased systemic complement activation and less severe disease compared with patients with normal MBL levels [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In cystic fibrosis patients, MBL deficiency is associated with earlier colonization with Pseudomonas, more rapid decline in lung function, and earlier death secondary to end-stage lung disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39095?source=see_link\">",
"       \"Cystic fibrosis: Genetics and pathogenesis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The effect of MBL deficiency in patients receiving chemotherapy is variable [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/18\">",
"       18",
"      </a>",
"      ]. In most studies, MBL deficiency was associated with more prolonged episodes of febrile neutropenia and serious infections, such as bacteremia [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/2,3,18\">",
"       2,3,18",
"      </a>",
"      ]. However, this association was not seen in patients who were severely neutropenic or who had acute myeloid leukemia, most likely because the significant impairment in phagocytosis in these patients blunted any effect of MBL deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/18,43,44\">",
"       18,43,44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      MBL deficiency was more common, and median serum MBL levels were lower, in immunocompromised patients with acute invasive aspergillosis compared with control subjects [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      High levels of serum MBL were associated with protection against urinary tract infections and urosepsis after simultaneous pancreas and kidney transplantation (SPKT) [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/46\">",
"       46",
"      </a>",
"      ]. Liver transplant patients receiving a liver from an MBL deficient donor had a three to fourfold elevated chance of developing clinically significant infections [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/47-49\">",
"       47-49",
"      </a>",
"      ]. In addition, cytomegalovirus (CMV) reactivation was more common in liver transplant patients who had MBL deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      MBL2 defects in both the donor and recipient were also associated with major infection, especially after neutrophil recovery, in patients who underwent myeloablative, total body irradiation conditioning prior to hematopoietic cell transplantation versus reduced-intensity conditioning [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Low MBL levels, both pre- and postoperatively, were associated with significantly increased infection rates in patients who underwent major gastrointestinal surgery for malignant disease [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      MBL levels are inversely correlated with the frequency of lower respiratory tract infections and bronchiectasis in patients with common variable immunodeficiency. MBL deficiency may also be found in combination with IgG2 deficiency in infants and young children who present with recurrent infections. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/60/13258?source=see_link\">",
"       \"IgG subclass deficiency\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/45/38617?source=see_link\">",
"       \"Common variable immunodeficiency in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17866?source=see_link\">",
"       \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     In people with no other identified immunodeficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;MBL deficiency may be clinically relevant in some individuals who do not have other predisposing factors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A case-control study compared 228 adult patients with a history of recurrent",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      severe infections with 241 individuals without such a history [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/9\">",
"       9",
"      </a>",
"      ]. A higher prevalence of severe MBL deficiency (MBL level &le;50",
"      <span class=\"nowrap\">",
"       ng/mL)",
"      </span>",
"      was seen in patients with a history of recurrent",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      severe infections, particularly respiratory tract infections, compared with controls (12 versus 6 percent; OR 2.1, 95% CI 1.1-4.1). This difference persisted, even in the absence of concomitant immunodeficiency. However, the existence of other cofactors that influence the clinical phenotype in patients with MBL deficiency was suspected in this study for several reasons. Patients with severe MBL deficiency and recurrent",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      severe infections had a broad spectrum of clinical severity. No correlation was seen between severe MBL deficiency and severity of infection. Onset of recurrent",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      severe infections was not until adolescence or adulthood despite presumed longstanding MBL deficiency. In addition, 15 controls with no significant infection history had severe MBL deficiency.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Increased severity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low levels of MBL are associated with more severe disease and worse outcomes with certain infections, even in immunocompetent individuals.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In adults with community acquired pneumonia, MBL insufficiency and deficiency are associated with more severe outcomes, including sepsis, acute respiratory failure, and death [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Otherwise immunocompetent homozygotes for MBL variants",
"      <span class=\"nowrap\">",
"       (O/O)",
"      </span>",
"      appear to be at increased risk of invasive pneumococcal disease [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/54,55\">",
"       54,55",
"      </a>",
"      ]. The risk of death is increased among MBL-deficient patients with severe pneumococcal infection [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Low-expression MBL2 genotypes predisposed female patients with acute Escherichia coli-induced pyelonephritis to the development of septic shock, but not to bacteremia [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study in women with occluded Fallopian tubes who were seropositive or seronegative for Chlamydia trachomatis, which is a major cause of occlusion, wild-type allele A homozygosity was protective against occlusion, while carriage of the variant allele B was a risk factor for Fallopian tube occlusion [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/57\">",
"       57",
"      </a>",
"      ]. Variant MBL B allele carriage was highest in women with occlusion who had positive chlamydial serology.",
"     </li>",
"     <li>",
"      Persistent hepatitis B virus infection was associated with the low MBL-producing variant alleles B and D [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/58,59\">",
"       58,59",
"      </a>",
"      ]. High MBL serum levels were associated with increased survival rates among patients with hepatitis B [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/60,61\">",
"       60,61",
"      </a>",
"      ]. Results regarding the role of MBL in hepatitis C infection are inconsistent [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/62-65\">",
"       62-65",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The role of MBL in HIV infection and progression has been debated for several years. MBL is able to bind to the envelope protein of the HIV-1 virus (gp120) because it is highly glycosylated with N-linked carbohydrates [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/66,67\">",
"       66,67",
"      </a>",
"      ]. Thus, it is conceivable that MBL-mediated complement activation could facilitate the immune response directed against HIV infection. However, reports on the effects of MBL on HIV infection and progression are contradictory. Results on the effect of MBL on HIV disease progression have ranged from finding no effect [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/54\">",
"       54",
"      </a>",
"      ], to a negative effect of high MBL and a beneficial effect of low MBL [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/55,68\">",
"       55,68",
"      </a>",
"      ], to a beneficial effect of high MBL levels and negative effect of low MBL [",
"      <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/69-71\">",
"       69-71",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Increased susceptibility",
"    </span>",
"    &nbsp;&mdash;&nbsp;MBL deficiency is also associated with increased susceptibility to meningococcal disease, tuberculosis, and Legionnaires' disease; recurrent tonsillitis and vulvovaginitis; and poor immune response to influenza vaccination [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/58,59,72-79\">",
"     58,59,72-79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/50/27432?source=see_link\">",
"     \"Epidemiology of Neisseria meningitidis infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/32/7688?source=see_link\">",
"     \"Microbiology and pathobiology of Neisseria meningitidis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/1/15386?source=see_link\">",
"     \"Candida vulvovaginitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Autoimmunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is generally assumed that the recognition of self-determinants is confined to the adaptive immune system, and that the innate immune system plays little role in autoimmunity. However, evidence is growing that the innate immune system may contribute to autoimmunity, either by priming or promoting aggressive immune responses [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/80,81\">",
"     80,81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A major pathophysiologic concept of autoimmunity is impaired apoptotic cell clearance. MBL facilitates the clearance of apoptotic cells [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/82,83\">",
"     82,83",
"    </a>",
"    ]. Membrane carbohydrates are altered when a cell goes into apoptosis, leading to increased expression of fucose and N-acetyl-glucosamine [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. Redistribution or clustering of glycoproteins expressed on apoptotic cells may enable MBL to bind to these carbohydrates, thereby facilitating clearance [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/86,87\">",
"     86,87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MBL can alter the response that affected individuals have to a variety of medical conditions. In the presence of MBL deficiency, chronic inflammatory conditions may be more severe. Low MBL serum levels and MBL2 genetic polymorphisms with corresponding impaired MBL function appear to affect several autoimmune diseases:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Rheumatoid arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The data on the effect of MBL levels and rheumatoid arthritis are variable, depending upon patient factors and outcomes studied [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/88-94\">",
"     88-94",
"    </a>",
"    ]. Early disease onset and findings linked with poor prognosis, including reactive systemic amyloidosis and increased joint erosions and inflammation, are generally associated with low MBL levels [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/88-93\">",
"     88-93",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/11/2234?source=see_link\">",
"     \"Investigational biologic markers in the diagnosis and assessment of rheumatoid arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/63/23546?source=see_link\">",
"     \"HLA and other susceptibility genes in rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, a dose-dependent association was seen between MBL2 expression potential (indicated by structural genotypes and promoter polymorphisms) and disease activity and physical disability in anti-cyclic citrullinated peptide-positive patients with newly diagnosed rheumatoid arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/95\">",
"     95",
"    </a>",
"    ]. This finding is in accord with previous findings of increased serum concentrations of MBL in patients with rheumatoid arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MBL deficiency does not increase susceptibility to juvenile idiopathic arthritis (JIA), but it is associated with a younger age at onset of juvenile polyarthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/97\">",
"     97",
"    </a>",
"    ]. On the other hand, MBL-deficient children with juvenile oligoarthritis are more likely to go into remission than MBL-sufficient children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Systemic lupus erythematosus",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are also mixed reports regarding the relationship between MBL deficiency and systemic lupus erythematosus (SLE), although, on balance, low MBL levels are associated with SLE [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/98-100\">",
"     98-100",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/43/37562?source=see_link\">",
"     \"Epidemiology and pathogenesis of systemic lupus erythematosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Autoantibodies against MBL were more commonly elevated [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/101\">",
"     101",
"    </a>",
"    ], and MBL levels lower [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/102\">",
"     102",
"    </a>",
"    ], in patients with quiescent than active SLE. MBL down-regulating promoter polymorphisms were associated with juvenile-onset SLE and higher risk of cutaneous manifestations and cardiopulmonary complications [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/63\">",
"     63",
"    </a>",
"    ]. Low serum MBL levels also predisposed patients with SLE to more major infections, particularly bacterial infections [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/64,102\">",
"     64,102",
"    </a>",
"    ]. In addition, SLE patients with MBL-deficient genotypes were more likely to have cardiovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/65\">",
"     65",
"    </a>",
"    ] and increased intima-media thickness of the common carotid artery [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/103\">",
"     103",
"    </a>",
"    ], although these findings may be due to the association of this genotype with antiphospholipid antibodies. High MBL expression genotypes were associated with an increased risk of renal disorders in children with SLE [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/102\">",
"     102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, one study found there was no increase of severe MBL deficiency in SLE, nor an association between low MBL levels and infection [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/66\">",
"     66",
"    </a>",
"    ]. Another study found that MBL genotype status did not affect the course or outcome of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Celiac disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The MBL",
"    <span class=\"nowrap\">",
"     O/O",
"    </span>",
"    genotype is associated with celiac disease and an increased risk of developing secondary autoimmune diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data regarding the association between MBL levels and early onset of diabetes are conflicting. One study found higher levels of MBL in patients with juvenile diabetes than in siblings without diabetes or in healthy controls [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/105\">",
"     105",
"    </a>",
"    ]. Conversely, another study found that individuals who developed type 1 diabetes during childhood and adolescence were more likely to possess a variant allele than healthy controls [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/106\">",
"     106",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Ischemia/reperfusion injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue damage and impaired organ function as a result of",
"    <span class=\"nowrap\">",
"     ischemia/reperfusion",
"    </span>",
"    <span class=\"nowrap\">",
"     (I/R)",
"    </span>",
"    injury remain major hurdles in solid organ transplantation. The hypoxic state to which an organ is subjected during organ harvesting, transport, and implantation results in activation of various immunologic events [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/107\">",
"     107",
"    </a>",
"    ]. The complement system plays an important role in mediating tissue injury after oxidative stress. Activation and deposition of complement on the vascular endothelium occurs following oxidative stress [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/108,109\">",
"     108,109",
"    </a>",
"    ]. Tissue injury after",
"    <span class=\"nowrap\">",
"     I/R",
"    </span>",
"    is significantly reduced by complement inhibition [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/80,110\">",
"     80,110",
"    </a>",
"    ]. Complement activation via the lectin pathway occurs following oxidative stress, indicating that inhibition of MBL could be a novel approach in reducing",
"    <span class=\"nowrap\">",
"     I/R",
"    </span>",
"    damage [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/111\">",
"     111",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MBL may contribute to the pathogenesis of inflammation-induced vascular damage both in the transplanted organ and in the recipient's native blood vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/112\">",
"     112",
"    </a>",
"    ]. MBL-depositions are observed early after transplantation of ischemically injured kidneys [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/113\">",
"     113",
"    </a>",
"    ]. In addition, high MBL levels are associated with a more severe form of rejection leading to graft loss in kidney, heart, and lung transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/114-116\">",
"     114-116",
"    </a>",
"    ]. Graft and patient survival following simultaneous pancreas and kidney transplantation (SPKT) is significantly better in recipients with MBL gene polymorphisms associated with low MBL levels. These findings identify higher levels of MBL as a potential risk factor for graft and patient survival in solid organ transplantation.",
"   </p>",
"   <p>",
"    Infection risk in solid organ transplantation patients is discussed above (see",
"    <a class=\"local\" href=\"#H10\">",
"     'In immunocompromised hosts'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Vascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;MBL binds to intracellular components of endothelial cells during",
"    <span class=\"nowrap\">",
"     ischemia/reperfusion",
"    </span>",
"    injury, activating the lectin pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/81,111\">",
"     81,111",
"    </a>",
"    ]. In a prospective study performed in patients with severe carotid atherosclerosis, the degree of early restenosis was significantly higher in patients homozygous for the normal MBL2 genotype (allele A) compared with patients with MBL2 variant genotypes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/117\">",
"     117",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Furthermore, sustained MBL deficiency may be a favorable status for patients undergoing cardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/118\">",
"     118",
"    </a>",
"    ]. After cardiac surgery, patients with MBL deficiency did not develop multiple organ dysfunction syndrome unless they had been transfused with fresh frozen plasma (containing MBL from donors). Patients expressing the combined MBL2 LYQA high-secretor haplotype have a significantly higher incidence of postoperative myocardial infarction after primary coronary artery bypass graft surgery than patients who do not express this haplotype [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/119\">",
"     119",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A major source of mortality and morbidity in diabetes is microvascular complications. A substantial portion of patients with diabetes develops diabetic nephropathy and retinopathy. Higher levels of MBL are associated with diabetic microvascular complications. Several studies show an association between an increased risk of developing renal failure and high MBL-producing genotypes in patients with diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/120-122\">",
"     120-122",
"    </a>",
"    ], although this relationship is inconsistent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/123\">",
"     123",
"    </a>",
"    ]. The exact immunologic processes involving the role of MBL in the pathogenesis of diabetic nephropathy are still unclear. In contrast, high MBL levels may predict a decreased likelihood of myocardial infarction in patients with diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/124\">",
"     124",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conversely, high MBL levels were associated with an increased risk of ischemic heart disease and myocardial infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/125\">",
"     125",
"    </a>",
"    ] and risk of both cardiovascular death and death from all causes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/126\">",
"     126",
"    </a>",
"    ] in a cohort of Danish patients with rheumatoid arthritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The MBL genotype appears to influence oncologic disease. Low MBL-producing variants are associated with increased risk of gastric cancer and more advanced phenotypes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/127-129\">",
"     127-129",
"    </a>",
"    ]. In addition, MBL-deficient oncologic patients that require surgery have a higher risk of developing postoperative complications. However, the opposite is seen with promoter polymorphisms. The X allele of the",
"    <span class=\"nowrap\">",
"     Y/X",
"    </span>",
"    promoter polymorphism (resulting in lower MBL levels) is associated with improved lung cancer survival [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/130\">",
"     130",
"    </a>",
"    ]. Promoter polymorphisms that result in higher MBL levels are associated with increased susceptibility to human papillomavirus infection [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/131\">",
"     131",
"    </a>",
"    ], but not increased risk for cervical cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/132\">",
"     132",
"    </a>",
"    ]. MBL deficiency, defined as an MBL level &lt;200",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    was associated with decreased event-free survival in pediatric oncology patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/133\">",
"     133",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;MBL deficiency is generally defined as a serum level &lt;500",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    or MBL activity below 200",
"    <span class=\"nowrap\">",
"     U/mL,",
"    </span>",
"    depending on the assay used. Alternatively, MBL deficiency is sometimes defined as partial (&gt;50 to 1000",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    or severe (&le;50",
"    <span class=\"nowrap\">",
"     ng/mL).",
"    </span>",
"    Antigenic measurement of MBL serum concentration is becoming a widely available diagnostic test. However, there is no consensus on the relevance of MBL deficiency or its treatment. Thus, there are no standard guidelines regarding which patients to test.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Indications for testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The authors suggest performing an evaluation of all arms of the complement system (classical, alternative, and lectin pathways) in individuals with recurrent",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    severe respiratory tract infections and in patients immunocompromised for other reasons, such as transplantation patients with recurrent infections who have decreased cellular immunity due to immunosuppressive drug therapy, since these are the patients most likely to benefit from the available therapy. Testing includes total hemolytic complement (CH50), alternative pathway hemolytic (AH50), and MBL assays. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/25/10647?source=see_link\">",
"     \"Overview and clinical assessment of the complement system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Laboratory evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impairment of the lectin pathway is almost always due to MBL defects. In addition, there is a strong correlation between MBL serum concentration and MBL activity. Thus, antigenic measurement of MBL serum concentration is an appropriate screening test for MBL deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/134\">",
"     134",
"    </a>",
"    ]. However, this method will not detect rarer causes of impairment of the lectin pathway due to mutations in the mannan-binding lectin-associated protease (MASP) or ficolin genes. The activation assay is an alternative test that can detect impairment due to MBL, MASP, or ficolin defects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/58/42920?source=see_link&amp;anchor=H13#H13\">",
"     \"Inherited disorders of the complement system\", section on 'Lectin pathway deficiencies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Further evaluation by functional tests or genotyping is usually not necessary. Testing only by genotyping is not recommended, because MBL levels can differ by 10-fold in individuals with identical genotypes for all of the known MBL variants [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/8\">",
"     8",
"    </a>",
"    ]. In addition, patients with low levels of MBL can be missed by genotyping for only the exon 1 variants, but not the promoter polymorphisms (eg, patients with the LXPA haplotype would be grouped with those with normal MBL levels). The other components of the lectin pathway, the MBL associated serine proteases (MASPs) and ficolins, can be analyzed if the MBL2 gene is normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with recurrent infections should be treated similarly to other patients with complement deficiencies. This includes prompt treatment with antibiotics with each febrile infection and possible prophylactic antibiotics, as is done with patients who are post-splenectomy or who have symptomatic IgA deficiency. In addition, these patients should receive pneumococcal and meningococcal vaccines, with documentation of antibody responses. MBL substitution therapy is available, but its short half-life limits its utility to patients with acute, severe infections. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24570?source=see_link\">",
"     \"Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7561?source=see_link\">",
"     \"Secondary immune deficiency due to miscellaneous causes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/58/42920?source=see_link\">",
"     \"Inherited disorders of the complement system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     MBL substitution therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Animal studies and phase",
"    <span class=\"nowrap\">",
"     I/II",
"    </span>",
"    human studies suggest that replacement therapy with plasma-derived MBL is safe. However, it is still an experimental treatment, of which the clinical importance has yet to be established [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/4,135-138\">",
"     4,135-138",
"    </a>",
"    ]. At this time, there are no guidelines for its clinical use.",
"   </p>",
"   <p>",
"    The only MBL substitution product available to date is administered intravenously and has a relatively short half-life [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/139\">",
"     139",
"    </a>",
"    ]. The mean half-life of plasma-derived MBL is around 70 hours (range 15 to 115) in healthy adult volunteers and adult patients with Staphylococcus aureus septicaemia, and around 36 hours (range 24 to 67) in children with chemotherapy-induced neutropenia. In a study of 10 pediatric oncology patients with chemotherapy-induced neutropenia who received twice weekly MBL infusions, all patients reached trough MBL levels of &ge;1",
"    <span class=\"nowrap\">",
"     mcg/mL,",
"    </span>",
"    a level sufficient for opsonization in healthy individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/140\">",
"     140",
"    </a>",
"    ]. However, these patients all had suboptimal levels of opsonophagocytosis. Insufficient opsonic function may be due to additional complement deficiencies in these patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patients most likely to benefit from this therapy are those with acute, severe infections who have impairment in multiple levels of the immune system, for example neonates with immature immune systems or transplantation patients with insufficient cellular immunity who also have MBL deficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;In adults a dose of 6 mg of plasma-derived MBL given two to three times weekly [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/4,23\">",
"     4,23",
"    </a>",
"    ] or a dose of 0.3",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    given two to three times daily [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/141\">",
"     141",
"    </a>",
"    ] results in plasma levels around 1000",
"    <span class=\"nowrap\">",
"     ng/mL.",
"    </span>",
"   </p>",
"   <p>",
"    In",
"    children a dose of 0.3",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    also results in plasma levels that remain above 1000",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    for about three days [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/139\">",
"     139",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adverse effects have not been reported to date [",
"    <a class=\"abstract\" href=\"UTD.htm?19/14/19690/abstract/4,23,139,141\">",
"     4,23,139,141",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mannose-binding lectin (MBL) is a protein involved in complement activation via the lectin pathway (",
"      <a class=\"graphic graphic_figure graphicRef60513 \" href=\"UTD.htm?34/45/35550\">",
"       figure 1",
"      </a>",
"      ). As part of the innate immune system, the complement system provides immediate defense against infection and has proinflammatory effects. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Decreased levels of MBL can result from mutations in the MBL2 gene or its promoter. Persons with mutations of both MBL2 alleles constitute about 3 to 5 percent of the population. Heterozygosity is found in up to 30 percent of the population. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12420?source=see_link&amp;anchor=H2#H2\">",
"       \"Mannose-binding lectin\", section on 'The MBL gene'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MBL binds to carbohydrates on microbes or unwanted material and triggers the activation of the lectin pathway, but it does not recognize self carbohydrates. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12420?source=see_link&amp;anchor=H3#H3\">",
"       \"Mannose-binding lectin\", section on 'The MBL protein'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12420?source=see_link&amp;anchor=H4#H4\">",
"       \"Mannose-binding lectin\", section on 'The lectin pathway'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11190?source=see_link\">",
"       \"Complement pathways\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Plasma levels of MBL are stable over time. Serum levels of MBL range from less than 20 up to 10,000",
"      <span class=\"nowrap\">",
"       ng/mL.",
"      </span>",
"      Deficiency of MBL is defined as a serum level &lt;500",
"      <span class=\"nowrap\">",
"       ng/mL.",
"      </span>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12420?source=see_link&amp;anchor=H3#H3\">",
"       \"Mannose-binding lectin\", section on 'The MBL protein'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H7\">",
"       'Physiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Individuals generally benefit from normal levels of MBL. However, in some cases low levels appear to be advantageous. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In certain individuals, deficiency of MBL is associated with an increased frequency of pyogenic infections, especially encapsulated bacteria, due to defective opsonization. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the presence of MBL deficiency, chronic inflammatory conditions may be more severe. MBL can also alter the response that affected individuals have to a variety of medical conditions. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Autoimmunity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plasma-derived MBL substitution therapy is available, although it is still an experimental treatment. The patients with MBL deficiency most likely to benefit from this therapy are those with acute, severe infections who have impairment in multiple levels of the immune system. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'MBL substitution therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/1\">",
"      Eisen DP, Dean MM, Boermeester MA, et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis 2008; 47:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/2\">",
"      Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001; 358:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/3\">",
"      Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001; 358:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/4\">",
"      Valdimarsson H, Vikingsdottir T, Bang P, et al. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol 2004; 59:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/5\">",
"      Kruse C, Rosgaard A, Steffensen R, et al. Low serum level of mannan-binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous abortion. Am J Obstet Gynecol 2002; 187:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/6\">",
"      Sallenbach S, Thiel S, Aebi C, et al. Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr Allergy Immunol 2011; 22:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/7\">",
"      Gadjeva M, Takahashi K, Thiel S. Mannan-binding lectin--a soluble pattern recognition molecule. Mol Immunol 2004; 41:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/8\">",
"      Steffensen R, Thiel S, Varming K, et al. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 2000; 241:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/9\">",
"      Hoeflich C, Unterwalder N, Schuett S, et al. Clinical manifestation of mannose-binding lectin deficiency in adults independent of concomitant immunodeficiency. Hum Immunol 2009; 70:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/10\">",
"      Lotz DR, Knutsen AP. Concomitant selective antibody deficiency in pediatric patients with mannose-binding lectin deficiency. Pediatric Allergy, Immunology, and Pulmonology 2010; 23:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/11\">",
"      Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003; 37:1496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/12\">",
"      Garred P, Larsen F, Seyfarth J, et al. Mannose-binding lectin and its genetic variants. Genes Immun 2006; 7:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/13\">",
"      Minchinton RM, Dean MM, Clark TR, et al. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 2002; 56:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/14\">",
"      Van Till JW, Boermeester MA, Modderman PW, et al. Variable mannose-binding lectin expression during postoperative acute-phase response. Surg Infect (Larchmt) 2006; 7:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/15\">",
"      Turner MW, Dinan L, Heatley S, et al. Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians. Hum Mol Genet 2000; 9:1481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/16\">",
"      Lipscombe RJ, Sumiya M, Hill AV, et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992; 1:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/17\">",
"      Garred P. Mannose-binding lectin genetics: from A to Z. Biochem Soc Trans 2008; 36:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/18\">",
"      Thiel S, Frederiksen PD, Jensenius JC. Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 2006; 43:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/19\">",
"      Sprong T, van Deuren M. Mannose-binding lectin: ancient molecule, interesting future. Clin Infect Dis 2008; 47:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/20\">",
"      van de Geijn FE, Dolhain RJ, van Rijs W, et al. Mannose-binding lectin genotypes are associated with shorter gestational age. An evolutionary advantage of low MBL production genotypes? Mol Immunol 2008; 45:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/21\">",
"      Dahl M, Tybjaerg-Hansen A, Schnohr P, Nordestgaard BG. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med 2004; 199:1391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/22\">",
"      Dommett RM, Klein N, Turner MW. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 2006; 68:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/23\">",
"      Garred P, Pressler T, Lanng S, et al. Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease. Pediatr Pulmonol 2002; 33:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/24\">",
"      Oudshoorn AM, van den Dungen FA, Bach KP, et al. Mannose-binding lectin in term newborns and their mothers: genotypic and phenotypic relationship. Hum Immunol 2008; 69:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/25\">",
"      Ip WK, To YF, Cheng SK, Lau YL. Serum mannose-binding lectin levels and mbl2 gene polymorphisms in different age and gender groups of southern Chinese adults. Scand J Immunol 2004; 59:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/26\">",
"      Ytting H, Christensen IJ, Thiel S, et al. Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise. Scand J Immunol 2007; 66:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/27\">",
"      Thiel S, Holmskov U, Hviid L, et al. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 1992; 90:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/28\">",
"      Super M, Thiel S, Lu J, et al. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 1989; 2:1236.",
"     </a>",
"    </li>",
"    <li>",
"     Bouwman LH. Mannose binding lectin: The Dr. Jekyll and Mr. Hyde of the innate immune system. Thesis. In: Department of surgery, Leiden University, Leiden 2006. p.153.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/30\">",
"      Miller ME, Seals J, Kaye R, Levitsky LC. A familial, plasma-associated defect of phagocytosis: A new cause of recurrent bacterial infections. Lancet 1968; 292:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/31\">",
"      Soothill JF, Harvey BA. Defective opsonization. A common immunity deficiency. Arch Dis Child 1976; 51:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/32\">",
"      Candy DC, Larcher VF, Tripp JH, et al. Yeast opsonisation in children with chronic diarrhoeal states. Arch Dis Child 1980; 55:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/33\">",
"      Richardson VF, Larcher VF, Price JF. A common congenital immunodeficiency predisposing to infection and atopy in infancy. Arch Dis Child 1983; 58:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/34\">",
"      Turner MW, Mowbray JF, Harvey BA, et al. Defective yeast opsonization and C2 deficiency in atopic patients. Clin Exp Immunol 1978; 34:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/35\">",
"      Isra&euml;ls J, Frakking FN, Kremer LC, et al. Mannose-binding lectin and infection risk in newborns: a systematic review. Arch Dis Child Fetal Neonatal Ed 2010; 95:F452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/36\">",
"      Koch A, Melbye M, S&oslash;rensen P, et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 2001; 285:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/37\">",
"      Schlapbach LJ, Latzin P, Regamey N, et al. Mannose-binding lectin cord blood levels and respiratory symptoms during infancy: a prospective birth cohort study. Pediatr Allergy Immunol 2009; 20:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/38\">",
"      Garred P, J Str&oslash;m J, Quist L, et al. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 2003; 188:1394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/39\">",
"      Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/40\">",
"      Fidler KJ, Wilson P, Davies JC, et al. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med 2004; 30:1438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/41\">",
"      Hellemann D, Larsson A, Madsen HO, et al. Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. Hum Mol Genet 2007; 16:3071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/42\">",
"      Sprong T, Mollnes TE, Neeleman C, et al. Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock. Clin Infect Dis 2009; 49:1380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/43\">",
"      Frakking FN, van de Wetering MD, Brouwer N, et al. The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. Eur J Cancer 2006; 42:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/44\">",
"      Rubnitz JE, Howard SC, Willis J, et al. Baseline mannose binding lectin levels may not predict infection among children with leukemia. Pediatr Blood Cancer 2008; 50:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/45\">",
"      Lambourne J, Agranoff D, Herbrecht R, et al. Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients. Clin Infect Dis 2009; 49:1486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/46\">",
"      Verschuren JJ, Roos A, Schaapherder AF, et al. Infectious complications after simultaneous pancreas-kidney transplantation: a role for the lectin pathway of complement activation. Transplantation 2008; 85:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/47\">",
"      Worthley DL, Johnson DF, Eisen DP, et al. Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation. Clin Infect Dis 2009; 48:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/48\">",
"      Bouwman LH, Roos A, Terpstra OT, et al. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005; 129:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/49\">",
"      de Rooij BJ, van Hoek B, ten Hove WR, et al. Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation. Hepatology 2010; 52:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/50\">",
"      Kwakkel-van Erp JM, Paantjens AW, van Kessel DA, et al. Mannose-binding lectin deficiency linked to cytomegalovirus (CMV) reactivation and survival in lung transplantation. Clin Exp Immunol 2011; 165:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/51\">",
"      Mullighan CG, Heatley S, Doherty K, et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99:3524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/52\">",
"      Siassi M, Hohenberger W, Riese J. Mannan-binding lectin (MBL) serum levels and post-operative infections. Biochem Soc Trans 2003; 31:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/53\">",
"      Garcia-Laorden MI, Sole-Violan J, Rodriguez de Castro F, et al. Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. J Allergy Clin Immunol 2008; 122:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/54\">",
"      McBride MO, Fischer PB, Sumiya M, et al. Mannose-binding protein in HIV-seropositive patients does not contribute to disease progression or bacterial infections. Int J STD AIDS 1998; 9:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/55\">",
"      Hundt M, Heiken H, Schmidt RE. Low mannose-binding lectin serum concentrations in HIV long-term nonprogressors? AIDS Res Hum Retroviruses 2000; 16:1927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/56\">",
"      Smithson A, Mu&ntilde;oz A, Suarez B, et al. Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to Escherichia coli. Clin Vaccine Immunol 2007; 14:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/57\">",
"      Sziller I, Babula O, Ujh&aacute;zy A, et al. Chlamydia trachomatis infection, Fallopian tube damage and a mannose-binding lectin codon 54 gene polymorphism. Hum Reprod 2007; 22:1861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/58\">",
"      Garred P, Harboe M, Oettinger T, et al. Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet 1994; 21:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/59\">",
"      Tang YW, Li H, Wu H, et al. Host single-nucleotide polymorphisms and altered responses to inactivated influenza vaccine. J Infect Dis 2007; 196:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/60\">",
"      Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency--revisited. Mol Immunol 2003; 40:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/61\">",
"      Hakozaki Y, Yoshiba M, Sekiyama K, et al. Mannose-binding lectin and the prognosis of fulminant hepatic failure caused by HBV infection. Liver 2002; 22:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/62\">",
"      Sato R, Matsushita M, Miyata M, et al. Substances reactive with mannose-binding protein (MBP) in sera of patients with rheumatoid arthritis. Fukushima J Med Sci 1997; 43:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/63\">",
"      Jakab L, Laki J, Sallai K, et al. Association between early onset and organ manifestations of systemic lupus erythematosus (SLE) and a down-regulating promoter polymorphism in the MBL2 gene. Clin Immunol 2007; 125:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/64\">",
"      Mok MY, Ip WK, Lau CS, et al. Mannose-binding lectin and susceptibility to infection in Chinese patients with systemic lupus erythematosus. J Rheumatol 2007; 34:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/65\">",
"      Font J, Ramos-Casals M, Brito-Zer&oacute;n P, et al. Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2007; 46:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/66\">",
"      Bultink IE, Hamann D, Seelen MA, et al. Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus. Arthritis Res Ther 2006; 8:R183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/67\">",
"      Bertoli AM, Fern&aacute;ndez M, McGwin G Jr, et al. Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcome. Arthritis Rheum 2006; 54:1703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/68\">",
"      Maas J, de Roda Husman AM, Brouwer M, et al. Presence of the variant mannose-binding lectin alleles associated with slower progression to AIDS. Amsterdam Cohort Study. AIDS 1998; 12:2275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/69\">",
"      Singh KK, Lieser A, Ruan PK, et al. An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1-related disease in children. J Allergy Clin Immunol 2008; 122:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/70\">",
"      Boniotto M, Crovella S, Pirulli D, et al. Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression. Genes Immun 2000; 1:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/71\">",
"      Garred P, Madsen HO, Balslev U, et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 1997; 349:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/72\">",
"      Hibberd ML, Sumiya M, Summerfield JA, et al. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet 1999; 353:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/73\">",
"      Grasso DL, Guerci VI, Zocconi E, et al. MBL2 genetic polymorphisms in Italian children with adenotonsillar hypertrophy. Int J Pediatr Otorhinolaryngol 2007; 71:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/74\">",
"      Koturoglu G, Onay H, Midilli R, et al. Evidence of an association between mannose binding lectin codon 54 polymorphism and adenoidectomy and/or tonsillectomy in children. Int J Pediatr Otorhinolaryngol 2007; 71:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/75\">",
"      Eisen DP, Stubbs J, Spilsbury D, et al. Low mannose-binding lectin complement activation function is associated with predisposition to Legionnaires' disease. Clin Exp Immunol 2007; 149:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/76\">",
"      Alagarasu K, Selvaraj P, Swaminathan S, et al. Mannose binding lectin gene variants and susceptibility to tuberculosis in HIV-1 infected patients of South India. Tuberculosis (Edinb) 2007; 87:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/77\">",
"      de Messias-Reason IJ, Boldt AB, Moraes Braga AC, et al. The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm. J Infect Dis 2007; 196:1379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/78\">",
"      Cosar H, Ozkinay F, Onay H, et al. Low levels of mannose-binding lectin confers protection against tuberculosis in Turkish children. Eur J Clin Microbiol Infect Dis 2008; 27:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/79\">",
"      Denholm JT, McBryde ES, Eisen DP. Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis. Clin Exp Immunol 2010; 162:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/80\">",
"      Buerke M, Murohara T, Lefer AM. Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation 1995; 91:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/81\">",
"      Collard CD, Montalto MC, Reenstra WR, et al. Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1. Am J Pathol 2001; 159:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/82\">",
"      Nauta AJ, Castellano G, Xu W, et al. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J Immunol 2004; 173:3044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/83\">",
"      Roos A, Xu W, Castellano G, et al. Mini-review: A pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol 2004; 34:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/84\">",
"      Russell L, Waring P, Beaver JP. Increased cell surface exposure of fucose residues is a late event in apoptosis. Biochem Biophys Res Commun 1998; 250:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/85\">",
"      Duvall E, Wyllie AH, Morris RG. Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology 1985; 56:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/86\">",
"      Ogden CA, deCathelineau A, Hoffmann PR, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001; 194:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/87\">",
"      Nauta AJ, Raaschou-Jensen N, Roos A, et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 2003; 33:2853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/88\">",
"      Saevarsdottir S, Vikingsdottir T, Vikingsson A, et al. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study. J Rheumatol 2001; 28:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/89\">",
"      Ip WK, Lau YL, Chan SY, et al. Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum 2000; 43:1679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/90\">",
"      Graudal NA, Homann C, Madsen HO, et al. Mannan binding lectin in rheumatoid arthritis. A longitudinal study. J Rheumatol 1998; 25:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/91\">",
"      Garred P, Madsen HO, Marquart H, et al. Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol 2000; 27:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/92\">",
"      Jacobsen S, Madsen HO, Klarlund M, et al. The influence of mannose binding lectin polymorphisms on disease outcome in early polyarthritis. TIRA Group. J Rheumatol 2001; 28:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/93\">",
"      Maury CP, Aittoniemi J, Tiitinen S, et al. Variant mannose-binding lectin 2 genotype is a risk factor for reactive systemic amyloidosis in rheumatoid arthritis. J Intern Med 2007; 262:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/94\">",
"      van de Geijn FE, Hazes JM, Geleijns K, et al. Mannose-binding lectin polymorphisms are not associated with rheumatoid arthritis--confirmation in two large cohorts. Rheumatology (Oxford) 2008; 47:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/95\">",
"      Jacobsen S, Garred P, Madsen HO, et al. Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis. J Rheumatol 2009; 36:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/96\">",
"      Saevarsdottir S, Steinsson K, Grondal G, Valdimarsson H. Patients with rheumatoid arthritis have higher levels of mannan-binding lectin than their first-degree relatives and unrelated controls. J Rheumatol 2007; 34:1692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/97\">",
"      Dolman KM, Brouwer N, Frakking FN, et al. Mannose-binding lectin deficiency is associated with early onset of polyarticular juvenile rheumatoid arthritis: a cohort study. Arthritis Res Ther 2008; 10:R32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/98\">",
"      Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2001; 2:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/99\">",
"      Lee YH, Witte T, Momot T, et al. The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. Arthritis Rheum 2005; 52:3966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/100\">",
"      Saevarsdottir S, Kristjansdottir H, Grondal G, et al. Mannan-binding lectin and complement C4A in Icelandic multicase families with systemic lupus erythematosus. Ann Rheum Dis 2006; 65:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/101\">",
"      Shoenfeld Y, Szyper-Kravitz M, Witte T, et al. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci 2007; 1108:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/102\">",
"      Tsai YC, Yeh KW, Yao TC, et al. Mannose-binding lectin expression genotype in pediatric-onset systemic lupus erythematosus: associations with susceptibility to renal disease and protection against infections. J Rheumatol 2011; 38:1429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/103\">",
"      Troelsen LN, Garred P, Christiansen B, et al. Genetically determined serum levels of mannose-binding lectin correlate negatively with common carotid intima-media thickness in systemic lupus erythematosus. J Rheumatol 2010; 37:1815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/104\">",
"      Boniotto M, Braida L, Baldas V, et al. Evidence of a correlation between mannose binding lectin and celiac disease: a model for other autoimmune diseases. J Mol Med (Berl) 2005; 83:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/105\">",
"      Bouwman LH, Eerligh P, Terpstra OT, et al. Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles. Diabetes 2005; 54:3002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/106\">",
"      Araujo J, Brand&atilde;o LA, Guimar&atilde;es RL, et al. Mannose binding lectin gene polymorphisms are associated with type 1 diabetes in Brazilian children and adolescents. Hum Immunol 2007; 68:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/107\">",
"      R&uuml;diger HA, Graf R, Clavien PA. Liver ischemia: apoptosis as a central mechanism of injury. J Invest Surg 2003; 16:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/108\">",
"      Weisman HF, Bartow T, Leppo MK, et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990; 249:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/109\">",
"      Collard CD, V&auml;kev&auml; A, B&uuml;k&uuml;soglu C, et al. Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation 1997; 96:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/110\">",
"      Collard CD, Agah A, Reenstra W, et al. Endothelial nuclear factor-kappaB translocation and vascular cell adhesion molecule-1 induction by complement: inhibition with anti-human C5 therapy or cGMP analogues. Arterioscler Thromb Vasc Biol 1999; 19:2623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/111\">",
"      Collard CD, V&auml;kev&auml; A, Morrissey MA, et al. Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol 2000; 156:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/112\">",
"      Berger SP, Roos A, Mallat MJ, et al. Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol 2007; 18:2416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/113\">",
"      de Vries B, Walter SJ, Peutz-Kootstra CJ, et al. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol 2004; 165:1677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/114\">",
"      Berger SP, Roos A, Mallat MJ, et al. Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant 2005; 5:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/115\">",
"      Fildes JE, Shaw SM, Walker AH, et al. Mannose-binding lectin deficiency offers protection from acute graft rejection after heart transplantation. J Heart Lung Transplant 2008; 27:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/116\">",
"      Munster JM, van der Bij W, Breukink MB, et al. Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation. Transplantation 2008; 86:1857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/117\">",
"      Rugonfalvi-Kiss S, D&oacute;sa E, Madsen HO, et al. High rate of early restenosis after carotid eversion endarterectomy in homozygous carriers of the normal mannose-binding lectin genotype. Stroke 2005; 36:944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/118\">",
"      Bilgin YM, Brand A, Berger SP, et al. Mannose-binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusions. Transfusion 2008; 48:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/119\">",
"      Collard CD, Shernan SK, Fox AA, et al. The MBL2 'LYQA secretor' haplotype is an independent predictor of postoperative myocardial infarction in whites undergoing coronary artery bypass graft surgery. Circulation 2007; 116:I106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/120\">",
"      Hovind P, Hansen TK, Tarnow L, et al. Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study. Diabetes 2005; 54:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/121\">",
"      Saraheimo M, Forsblom C, Hansen TK, et al. Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia 2005; 48:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/122\">",
"      Hansen TK, Tarnow L, Thiel S, et al. Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 2004; 53:1570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/123\">",
"      Aittoniemi J, Turpeinen H, Tiittanen M, et al. Relation among mannose-binding lectin 2 genotype, beta-cell autoantibodies, and risk for type 1 diabetes in Finnish children. Hum Immunol 2008; 69:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/124\">",
"      Saevarsdottir S, Oskarsson OO, Aspelund T, et al. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med 2005; 201:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/125\">",
"      Troelsen LN, Garred P, Madsen HO, Jacobsen S. Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. Arthritis Rheum 2007; 56:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/126\">",
"      Troelsen LN, Garred P, Jacobsen S. Mortality and predictors of mortality in rheumatoid arthritis--a role for mannose-binding lectin? J Rheumatol 2010; 37:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/127\">",
"      Wang FY, Tahara T, Arisawa T, et al. Mannan-binding lectin (MBL) polymorphism and gastric cancer risk in Japanese population. Dig Dis Sci 2008; 53:2904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/128\">",
"      Baccarelli A, Hou L, Chen J, et al. Mannose-binding lectin-2 genetic variation and stomach cancer risk. Int J Cancer 2006; 119:1970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/129\">",
"      Scudiero O, Nardone G, Omodei D, et al. A mannose-binding lectin-defective haplotype is a risk factor for gastric cancer. Clin Chem 2006; 52:1625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/130\">",
"      Pine SR, Mechanic LE, Ambs S, et al. Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J Natl Cancer Inst 2007; 99:1401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/131\">",
"      Tsai CC, Lin TM, You HL, Eng HL. Mannose-binding lectin in high-risk human papillomavirus infection. Am J Obstet Gynecol 2009; 200:618.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/132\">",
"      Segat L, Crovella S, Comar M, et al. MBL2 gene polymorphisms are correlated with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer. Hum Immunol 2009; 70:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/133\">",
"      Frakking FN, Brouwer N, Dolman KM, et al. Mannose-binding lectin (MBL) as prognostic factor in paediatric oncology patients. Clin Exp Immunol 2011; 165:51.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.ibtreflab.com/library/PDF/MBL%204-sided%20brochure.pdf (Accessed on February 11, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/135\">",
"      Bang P, Laursen I, Thornberg K, et al. The pharmacokinetic profile of plasma-derived mannan-binding lectin in healthy adult volunteers and patients with Staphylococcus aureus septicaemia. Scand J Infect Dis 2008; 40:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/136\">",
"      Valdimarsson H. Infusion of plasma-derived mannan-binding lectin (MBL) into MBL-deficient humans. Biochem Soc Trans 2003; 31:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/137\">",
"      Valdimarsson H, Stefansson M, Vikingsdottir T, et al. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol 1998; 48:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/138\">",
"      Laursen I, H&oslash;jrup P, Houen G, Christiansen M. Characterisation of the 1st SSI purified MBL standard. Clin Chim Acta 2008; 395:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/139\">",
"      Frakking FN, Brouwer N, van de Wetering MD, et al. Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia. Eur J Cancer 2009; 45:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/140\">",
"      Brouwer N, Frakking FN, van de Wetering MD, et al. Mannose-binding lectin (MBL) substitution: recovery of opsonic function in vivo lags behind MBL serum levels. J Immunol 2009; 183:3496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/14/19690/abstract/141\">",
"      Petersen KA, Matthiesen F, Agger T, et al. Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin. J Clin Immunol 2006; 26:465.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3932 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-01FC61200C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19690=[""].join("\n");
var outline_f19_14_19690=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Genotype/phenotype correlation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Physiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - In immunocompromised hosts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - In people with no other identified immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Increased severity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Increased susceptibility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Autoimmunity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Celiac disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Diabetes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Ischemia/reperfusion injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Vascular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Indications for testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      MBL substitution therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Indications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Dose",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/3932\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3932|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/45/35550\" title=\"figure 1\">",
"      Pathways of complement activation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/54/29542?source=related_link\">",
"      Acquired disorders of the complement system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/37/16986?source=related_link\">",
"      An overview of the innate immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/1/15386?source=related_link\">",
"      Candida vulvovaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17866?source=related_link\">",
"      Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/45/38617?source=related_link\">",
"      Common variable immunodeficiency in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11190?source=related_link\">",
"      Complement pathways",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39095?source=related_link\">",
"      Cystic fibrosis: Genetics and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/43/37562?source=related_link\">",
"      Epidemiology and pathogenesis of systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/50/27432?source=related_link\">",
"      Epidemiology of Neisseria meningitidis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/63/23546?source=related_link\">",
"      HLA and other susceptibility genes in rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/60/13258?source=related_link\">",
"      IgG subclass deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/58/42920?source=related_link\">",
"      Inherited disorders of the complement system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/11/2234?source=related_link\">",
"      Investigational biologic markers in the diagnosis and assessment of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/8/12420?source=related_link\">",
"      Mannose-binding lectin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/32/7688?source=related_link\">",
"      Microbiology and pathobiology of Neisseria meningitidis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/25/10647?source=related_link\">",
"      Overview and clinical assessment of the complement system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7561?source=related_link\">",
"      Secondary immune deficiency due to miscellaneous causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24570?source=related_link\">",
"      Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_14_19691="Clinical presentation of BO";
var content_f19_14_19691=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F58663&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F58663&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical presentation of bronchiolitis obliterans after lung transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Early",
"       </td>",
"       <td class=\"subtitle1\">",
"        Late",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Symptoms",
"       </td>",
"       <td>",
"        Nonproductive cough; dyspnea on exertion",
"       </td>",
"       <td>",
"        Productive cough; dyspnea at rest",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Physical examination",
"       </td>",
"       <td>",
"        Clear chest",
"       </td>",
"       <td>",
"        \"Pops and squeaks\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chest radiograph",
"       </td>",
"       <td>",
"        Clear",
"       </td>",
"       <td>",
"        Bronchiectasis, hyperinflation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary function tests",
"       </td>",
"       <td>",
"        Obstruction; most marked in mid flows FEF",
"        <sub>",
"         25-75",
"        </sub>",
"       </td>",
"       <td>",
"        Severe obstruction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sputum culture",
"       </td>",
"       <td>",
"        Negative",
"       </td>",
"       <td>",
"        Pseudomonas",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FEF",
"     <sub>",
"      25-75",
"     </sub>",
"     : forced expiratory flow between 25 and 75 percent of vital capacity.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19691=[""].join("\n");
var outline_f19_14_19691=null;
var title_f19_14_19692="Healthy weight parent tips";
var content_f19_14_19692=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78525&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78525&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Tips for maintaining a healthy weight: tips for parents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Be a good role model.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Children learn by example. Eat a variety of healthful foods and be physically active every day so that your children will learn healthful habits.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Offer structured meals and snacks.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Most children need food every 4 - 5 hours. Three meals and one snack time is appropriate for most school-aged children. Discourage between meal \"grazing.\" Plan meals and snacks ahead of time.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Disband the \"clean plate\" club.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Children are born with an innate sense of when they have had enough to eat. Encouraging them to eat past the point of fullness will result in weight gain.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Never use food as a reward or punishment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Food is for nourishing and fueling bodies. Instead, use non-food rewards such as special time spent together.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Remember the rules.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parents should be responsible for offering healthy foods and structured meals and snacks. Children should decide how much they eat. Be consistent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Choosing a weight maintenance program.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        The program should:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Be staffed with a variety of health professionals. The best",
"programs include pediatric dietitians, exercise physiologists,",
"physicians, and psychiatrists or psychologists.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Perform in depth medical assessment and medical monitoring.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Focus on the whole family, and not just the overweight child.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Be adapted to the specific age and capabilities of the child.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Focus on behavior changes including appropriate diet and physical activity.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Include a maintenance program or other support and referral",
"resources to deal with underlying issues that contributed to being",
"overweight.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19692=[""].join("\n");
var outline_f19_14_19692=null;
var title_f19_14_19693="Multivisceral transplant evaluation";
var content_f19_14_19693=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F59216&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F59216&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pre-transplant recipient evaluation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <strong>",
"         Referral to transplant center:",
"        </strong>",
"       </td>",
"       <td>",
"        Analysis of medical and surgical history, current medications, current enteral and parenteral nutrition requirements",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         History &amp; physical:",
"        </strong>",
"       </td>",
"       <td>",
"        Comprehensive history and physical including review of systems",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        <strong>",
"         Laboratory studies:",
"        </strong>",
"       </td>",
"       <td>",
"        Blood group",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tissue typing (HLA)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Panel of reactive antibody (PRA)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serology (CMV IgG and IgM, EBV IgG and IgM, HIV, HCV, HBeAg, HBsAg, HBsAb)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CBC, comprehensive metabolic panel, PT/PTT/INR",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        <strong>",
"         Imaging studies:",
"        </strong>",
"       </td>",
"       <td>",
"        Chest x-ray",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Doppler US of liver",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Doppler US of upper and lower extremities veins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CT scan abdomen and pelvis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Upper GI study, small bowel follow through",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Barium enema",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         Endoscopic studies:",
"        </strong>",
"       </td>",
"       <td>",
"        EGD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Colonoscopy",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        <strong>",
"         Motility studies:",
"        </strong>",
"       </td>",
"       <td>",
"        Gastro-esophageal motility studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Small intestine motility studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Colon transit time studies",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Liver:",
"        </strong>",
"       </td>",
"       <td>",
"        Liver biopsy",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        <strong>",
"         Cardiology evaluation:",
"        </strong>",
"       </td>",
"       <td>",
"        EKG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Baseline echocardiogram",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stress test and/or cardiac catheterization if &gt;50 years or with cardiac history, risk factors (HTN, DM)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        <strong>",
"         Nephrology evaluation:",
"        </strong>",
"       </td>",
"       <td>",
"        US abdomen with size of kidneys",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Triple renal scan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        24 hour creatinine clearance",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        <strong>",
"         Additional consults:",
"        </strong>",
"       </td>",
"       <td>",
"        Neurology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infectious disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Critical care",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anesthesia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"7\">",
"        <strong>",
"         Additional studies:",
"        </strong>",
"       </td>",
"       <td>",
"        Dental evaluation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mammogram",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PAP smear test",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Vaccinations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis A",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hepatitis B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pneumovax",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Multidisciplinary team evaluation:",
"        </strong>",
"       </td>",
"       <td>",
"        Final decision by transplant physician, surgeon, gastroenterologist, nurse coordinator, nutritionist and social worker",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CBC: complete blood count; CMV: cytomegalovirus; CT: computed tomography; DM: diabetes mellitus; EBV: Epstein-Barr virus; EGD: esophagogastroduodenoscopy; EKG: electrocardiogram; GI: gastrointestinal; HBeAg: hepatitis B e-antigen; HBsAb: hepatitis B surface antibody; HBsAG: hepatitis B surface antigen; HCV: hepatitis C virus; HIV: human immunodeficiency virus; HLA: human leukocyte antigen; HTN: hypertension; INR: international normalized ratio; PT: prothrombin time; PTT: partial thromboplastin time; US: ultrasound.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Farrukh Khan, MD and Gennaro Selvaggi, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19693=[""].join("\n");
var outline_f19_14_19693=null;
var title_f19_14_19694="Modified vasectomy forceps";
var content_f19_14_19694=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F59134&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F59134&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 517px\">",
"   <div class=\"ttl\">",
"    Modified vasectomy forceps",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 497px; height: 185px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The forceps used in vasectomy operations are ideal for removing deeply placed contraceptive implants. The forceps are modified so that the diameter of the circular grasper is reduced to slightly less than 2 mm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Speroff L, Darney PD. A Clinical Guide for Contraception, 5th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2011. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19694=[""].join("\n");
var outline_f19_14_19694=null;
var title_f19_14_19695="Pyriform aperture stenosis";
var content_f19_14_19695=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68161&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pyriform aperture stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial computed tomography image documenting the small nasal opening of pyriform aperture stenosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ellen S Deutsch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_14_19695=[""].join("\n");
var outline_f19_14_19695=null;
